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There is a fundamental connection between growth and nutrient 
availability. An inbalance between energy intake and energy expenditure can 
lead to the common diseases of the developed world, including type 2 diabetes, 
obesity, heart disease and cancer, as well as less common diseases such as 
anorexia, malnutrition and sarcopenia. The tight link between growth and nutrient 
availability is extended beyond the whole body level down to a cellular level. 
There exist cell autonomous signaling mechanisms that allow the cell to detect 
the environmental conditions and decide to grow, through increase in cell size or 
cell division. Malfunctions in these signaling pathways are fundamental to many 
of the diseases related to energetic misregulation. Many of the proteins that are 
central to these signaling pathways have also become good therapeutic targets. 
Two well characterized proteins that are central to cellular energy balance are 
AMPK and TOR. In response to depleted cellular ATP levels AMPK is activated 
in order to up-regulate ATP generating pathways and downregulate ATP 
consuming pathways, including growth. However as nutrients become available 
TOR is rapidly activated in order to efficiently utilize the available nutrients for 
growth. As our understanding of the function of these two proteins has increased, 
AMPK and TOR have become effective therapeutic targets. PAS kinase is a 
newly characterized serine/threonine kinase that can respond to the extracellular 
	  conditions in order to regulate nutrient partitioning and provide a progrowth 
signal. We show here that in budding yeast PAS kinase can respond to 
environmental cues to phosphorylate the metabolic enzyme Ugp1. P-Ugp1 then 
nucleates the formation of a unique signaling complex that includes Rom2 and 
Ssd1. Complex formation is able to activate the small GTPase Rho1, which 
functions as a progrowth signal. We also show that PASK-/- mice are resistant to 
the damaging effects of a high fat diet, specifically, obesity, insulin resistance and 
hepatic steatosis.  This protection is likely due to the increased metabolic rate of 
PASK-/- mice. The hypermetabolic phenotype of the PASK-/- can be 
recapitulated in cultured cells, which indicates that the increased metabolic rate is 
due to a cell autonomous change in metabolism. Further characterization of PAS 
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Energy homeostasis and growth  
 
 The ability of organisms to recognize and respond to a diverse 
extracellular environment is critical for survival. Organisms must be able to adapt 
to environmental stress and reproduce in order to have any fitness advantage. 
An organismʼs fitness advantage is largely determined by its ability to maintain 
energy homeostasis. Energy homeostasis is the process by which organisms are 
able to acutely respond to changes in the nutritional environment in order to 
sustain energy demand. This flexibility allows organisms to rapidly increase 
catabolic processes in response to nutrient-replete conditions in order to 
efficiently utilize available nutrients for growth and reproduction. Conversely, this 
flexibility allows organisms to increase anabolic processes in nutrient-deplete 
conditions in order to efficiently use energy stores until conditions become more 
advantageous for reproduction and growth. In higher eukaryotes these 
appropriate metabolic adaptations are partially controlled via the central nervous 
system. The nervous system monitors whole body energy homeostasis primarily 
through the endocrine system, which includes but is not limited to the brain, liver, 
gut, and pancreas(4).  
In addition to the central control of metabolism seen in many metazoa, 
multicellular organisms have cell autonomous mechanisms of metabolic 
regulation(2, 3, 5). Cell autonomous regulation of metabolism allows each cell to 
respond to fluctuations within its unique microenvironment to maximize the 
efficient utilization of nutrients. The cell contains many mechanisms that are able 
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to detect changes in either the availability of nutrients or the energy status of the 
cell. Once these mechanisms are activated they modulate cellular nutrient 
utilization through complex, integrated signaling networks. Under conditions of 
nutrient abundance these signaling networks lead to an increase in nutrient 
uptake and growth, through protein synthesis and cell division(6). In nutrient 
deplete conditions other signaling networks regulate cellular nutrient conservation 
and energy production(7). These networks up-regulate autophagy, mobilize 
energy stores and inhibit growth by decreasing protein synthesis and inhibiting 
cell cycle progression. These represent the two extremes of nutrient availability. 
However most organisms live in a more complex environment. Given the 
complexity of the nutritional milieu as well as other extracellular signals, such as 
growth factors or toxins, cellular growth decisions must integrate multiple inputs. 
Signal integration happens through overlap, or cross talk, between signaling 
pathways. Integration allows the cell to efficiently utilize available nutrients to 
grow or conserve nutrients in times of starvation in order to survive.  
Our understanding of cellular signaling mechanisms involved in coupling 
nutrient utilization to growth has increased with the detailed characterization of 
PAS kinase. Specifically, we have been able to show that PAS kinase, a 
conserved serine/threonine kinase, can control growth in response to stress in 
budding yeast and is required for normal energy homeostasis in the mouse(8).  
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PAS kinase function in S. cerevisiae 
The decision to grow or reproduce under conditions of nutrient limitation 
can be catastrophic for any organism. Each cell, within an organism, contains 
mechanisms that are designed to detect changes to nutrient availability and 
respond appropriately. These signaling mechanisms are designed to couple 
nutrient availability to growth to prevent cell death. Given the fundamental 
relationship between nutrients and growth, many signaling mechanisms that 
couple the two are highly conserved over evolution(9). This conservation has 
allowed us to use S. cerevisiae as a tool to dissect these complex signaling 
networks. Polarized cell growth in S. cerevisiae requires the coordinate up-
regulation of cell wall/membrane synthesis, protein synthesis, polarized 
localization of protein and mRNA, and DNA replication(6, 10-13). If any of these 
processes proceed out of sync with the others it can be lethal to the cell. The 
TOR signaling network is one mechanism that is able to respond to nutrient-
replete conditions to coordinate cell growth and division(13, 14). In order to 
regulate these diverse cellular processes the TOR signaling network overlaps 
with many other networks(7). The ability to coordinate polarized cell growth 
through the TOR signaling network is essential in S. cerevisiae(15). However, 
when TOR signaling is compromised, PAS kinase activation is necessary and 
sufficient to sustain growth.  
Here we show that the phosphorylation of Ugp1 via PAS kinase plays two 
roles. First, it increases cell wall biosynthesis at the expense of glycogen 
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storage(12). Phosphorylation of Ugp1 does not affect enzymatic activity. 
However it does regulate localization of the protein to the cell periphery. At the 
cell periphery the product of Ugp1ʼs enzymatic reaction is used predominantly for 
production of cell wall glucans. Second, it nucleates the formation of a pro-growth 
signaling complex that includes Ssd1 and Rom2. The translocation of Ugp1, 
mediated via PAS kinase phosphorylation, may be required for the formation of 
competent signaling complexes. Localizing to the cell periphery would bring the 
complex into proximity with Rho1, which is known to localize to the cell 
periphery(16). It may be that all of these proteins (PAS kinase, Rom2, Ssd1, 
Ugp1, Rho1) require independent inputs to translocate to the cell periphery, 
allowing the complex to integrate multiple inputs. Phosphorylation of Ugp1 allows 
coordination of polarized cell growth with an increase in cell wall synthesis that is 
required to accommodate the dramatic increase in size that is concomitant with 
cell division. This is the first evidence that Ugp1, thought only to catalyze the 
formation of UDP-glucose, plays a role in coupling the nutritional environment to 
growth. 	  	   	  
Target-Of-Rapamycin (TOR1/TOR2) function 
The target-of-rapamycin (TOR) is a highly conserved lipid kinase of the 
phosphoinositide 3-kinase (PI3K)-related protein kinases (PIKK) family. TOR 
functions as a master regulator of cell and organismal size. TOR was first 
identified as the target of the immunosuppressant rapamycin(17). Since its 
discovery, TOR has been extensively studied  
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for its ability to control cell size in response to nutrient availability. The 
domain organization of TOR can been seen in Figure 1-1, which consists of N-
terminal HEAT (huntingtin, elongation factor 3, A subunit of type 2A protein 
phosphatase, TOR) repeats that mediate protein-protein interactions and target 
TOR to the cell periphery(3, 18). The HEAT repeats are followed by a FAT 
domain (FRAP, ATM, TTRAP), which may also be involved in protein binding. 
The FKBP12-rapamycin binding site is localized between the FAT domain and 
the kinase domain of TOR and can disrupt some TOR-protein interactions. The 
C-terminus of TOR contains a FAT domain that is thought to be involved in 
redox-dependent degradation. 
The S. cerevisiae genome contains two paralogs of TOR: TOR1 and 
TOR2. The protein products of these two genes function in two distinct 
complexes termed TOR complex 1 (TORC1) and TOR complex 2 (TORC2) 
(Figure 1-2)(13). TORC1, which contains either Tor1 or Tor2 as well as Kog1 
(raptor), Tco89 and Lst8, regulates protein synthesis and cell size in response to 
nutrient availability. TORC1 function is sensitive to the inhibitor rapamycin. 
TORC2, which contains Tor2 (but not Tor1), Avo1, Avo2, Avo3 (Tsc11 or rictor), 
Bit61 and Lst8, is essential for cell division and cell cycle- dependent polarization 




















Figure 1-1).  Domain organization of Tor. The domain organization is the same 
for Tor1 and Tor2. The HEAT repeats and FAT domains have been shown to 
mediate the majority of the many protein-protein interactions of TOR. This domain 
organization is highly conserved across eukaryotes.	  Adapted from	  reference	  (3)	  







Figure	  1-­2).	  	  TORC1	  and	  TORC2	  signaling	  in	  budding	  yeast.	  TOR	  signaling	  controls	  both	  spatial	  and	  temporal	  aspects	  of	  cell	  growth.	  	  TORC1	  responds	  to	  nutrients	  to	  increase	  anabolic	  processes	  and	  cell	  size.	  TORC2	  regulates	  actin	  polarization	  and	  cell	  wall	  synthesis	  in	  a	  cell	  cycle	  dependent	  manner	  	  .	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The FKB12-rapamycin sensitive TORC1 contains either TOR1 or TOR2. 
TORC1 is activated in response to nutrients and regulates both catabolic and 
anabolic processes(19). TORC1 signaling can be divided into two signaling 
branches: one that inhibits scavenging mechanisms and utilization of energy 
stores, and a second that up-regulates protein synthesis and nutrient storage. 
TOR activation inhibits the transcription factors Gln3 and Gcn4, which are 
required for nitrogen scavenging and amino acid biosynthesis, respectively(20).  
Repression of these transcription factors is mediated through regulation of 
protein phosphatase-2A (PP2A) and other PP2A-related protein phosphatases 
via TORC1. This is coupled to a repression of autophagy via hyper-
phosphorylation of Atg13, which is a regulatory subunit of the 
autophagosome(21). Through these, as well as other mechanisms, TORC1 
activation leads to a repression of cellular recycling processes. The repression of 
cellular recycling is coupled to an up-regulation of cell growth and nutrient uptake. 
TORC1 regulates global protein synthesis, and thereby cell size, via expression 
of ribosomal genes as well as stabilization of the 5ʼ-cap dependent translation 
initiation factor eIF4G(22, 23). TORC1 up-regulates nutrient uptake via control of 
amino acid permease translocation to the plasma membrane mediated via 
Lst8(24). Lst8, a component of TORC1, controls amino acid permease sorting 
within the late secretory pathway.  
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The function of TORC2 is not as well characterized as its counterpart 
TORC1. However it is clear that activation of TORC2 leads to polarization of the 
actin cytoskeleton, which promotes cell division(25). The TORC2-dependent  
polarization of the actin cytoskeleton is dependent on the small GTPase Rho1. 
The mechanism by which TORC2 activates Rho1 to polarize the actin  
cytoskeleton remains somewhat ambiguous. However TORC2 activates the AGC 
kinase Ypk2 via direct phosphorylation of the hydrophobic and turn motifs(11). It 
has also been shown that expression of a constitutively active Ypk2 is able to 
suppress a loss of TORC2. These data taken together suggest that TORC2 
phosphorylates Ypk2, which in turn leads to Rho1 activation and actin 
polarization. Ypk2 phosphorylation also leads to an up-regulation of de novo 
ceramide biosynthesis, which may have a role in regulating endocytosis(26). 
TORC2 can also indirectly mediate actin polarization through activation of two 
related kinases, Slm1 and Slm2. Through coordination of all of these signaling 
pathways, TORC2 functions as a regulator of spatial growth in s. cerevisiae.  
In order to study the essential function of TOR2, mutants have been 
constructed that allow for the acute disruption of Tor2 activity. Strains harboring a 
temperature sensitive allele of TOR2 (tor2ts) arrest growth at the restrictive 
temperature (37° C)(27). This is due to a lack of functional TORC2 and 
decreased activation of Rho1. As expected, this growth arrest can be suppressed 
by over-expression of proteins that activate Rho1. The growth arrest of the tor2ts 
is also suppressed by growth on nonfermentative carbon sources (galactose, 
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raffinose, which are fermentable but do not elicit glucose repression) but not on 
nonfermentable carbon sources (glycerol, ethanol). Unexpectedly, treatment with 
cell wall/cell membrane perturbing agents, which cause cell integrity stress, can 
also abrogate the tor2ts phenotype. The mechanism underlying the connection 
between nonfermentative carbon sources, cell wall stress and suppression of the 
tor2ts remains unresolved. These data suggest the presence of signaling 
modalities that integrate input from cell integrity stress and metabolism to control 
cell growth. Properly coordinating these disparate signaling inputs into a 
concerted drive towards growth requires a complex interconnected signaling 
network.   
   
Per-Arnt-Sim kinase (PSK1/PSK2) 
In recent years many advances have come in our understanding of the 
inputs that are required for complex cell autonomous decision-making. One 
recent advance was the discovery and initial characterization of PAS kinase(28, 
29). PAS kinase consists of an N-terminal PAS domain and a C-terminal kinase 
domain. PAS domains have been well characterized in prokaryotic systems to 
function as molecular sensors of indicators of cellular metabolic status. The PAS 
domain is able to bind to and inhibit the kinase domain in cis. This raises the 
intriguing possibility that the PAS domain is able to directly sense metabolic 
changes within the cell to regulate kinase activity. This idea is supported by the 
observation that PAS kinase does not require activation loop phosphorylation in  
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order to be active(30). The small molecule(s) that regulate the PAS and kinase 
domain interaction remain to be elucidated. However, in a PAS kinase null strain 
(psk1∆ psk2∆) there is a dramatic increase in glycogen content at the expense of 
cell wall glucan, indicating an inability to properly regulate glucose flux(12). 
 In S. cerevisiae there are two PAS kinase paralogs, PSK1 and PSK2 
(referred to together as PAS kinase). PAS kinase can be activated by multiple 
inputs including cell integrity stress and cellular nutrient status (Fig 1-3)(31). 
Over-expression of Wsc1, an integral cell membrane protein, can lead to an 
activation of PAS kinase. This may be due to a direct interaction between Wsc1 
and PAS kinase or it may be that Wsc1 over-expression leads to cell integrity 
stress that is responsible for PAS kinase activation. The details of cell integrity 
stress activation of PAS kinase remain to be resolved. However activation leads 
to phosphorylation of Ugp1 at serine-11. Ugp1 is the enzyme responsible for the 
synthesis of UDP-glucose, which is the glucosyl donor for glycogen and cell wall 
glucan production(32). Phosphorylation of Ugp1 does not affect enzymatic 
activity, but rather the utilization of UDP-glucose. In the phosphorylated state 
Ugp1 produces UDP-glucose that is partitioned preferentially toward production 
of cell wall glucans. PAS kinase-dependent phosphorylation of Ugp1 increases 
production of cell wall glucans in order to stabilize the cell wall in response to cell 
integrity stress(12).  
 
 


















Figure	  1-­3).	  PAS	  kinase	  signaling	  in	  budding	  yeast.	  PAS	  kinase	  is	  activated	  by	  metabolic	  signals	  (nonfermentative	  carbon	  sources)	  as	  well	  as	  cell	  integrity	  stress	  (SDS,	  calcifluor	  white,	  congo	  red).	  Activation	  of	  PAS	  kinase	  leads	  to	  phosphorylation	  of	  the	  metabolic	  enzyme	  Ugp1.	  PAS	  kinase-­‐dependent	  phosphorylation	  of	  serine-­‐11	  of	  Ugp1	  induces	  a	  switch	  in	  glucose	  partitioning	  from	  storage	  (glycogen)	  to	  utilization	  (cell	  wall	  glucans).	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Yeasts are able to utilize a diverse array of carbon sources in order to  
extract the energy needed to grow. However in order to efficiently utilize available 
nutrients the cell must be able to dynamically regulate various metabolic 
programs(33). The preferred carbon source for yeast is glucose, which they 
ferment to ethanol. Growth on glucose leads to repression of metabolic programs 
involved in mitochondrial function as well as metabolism of alternative carbons 
sources. In response to growth on nonfermentative carbon sources, or carbon 
sources that do not activate glucose repression, PAS kinase is activated. Non-
fermentative activation of PAS kinase is dependent on SNF1/AMPK(31). 
However it is unclear if this is a direct or indirect effect of SNF1 activation. 
Activation of PAS kinase in response to these nutrient cues also leads to 
phosphorylation of Ugp1. When glucose is limiting in the environment it is 
presumably more efficient to use what is available to build cell wall rather than to 
store it as glycogen.  
All PAS kinase mutant phenotypes are completely phenocopied by 
introducing the Ugp1 serine-11 to alanine mutation (Ugp1-S11A), which prevents 
PAS kinase-dependent Ugp1 phosphorylation. This indicates that the effects of 
PAS kinase on glucose utilization are primarily mediated through Ugp1 
phosphorylation. However integrating PAS kinase function into broader signaling 
networks has remained elusive.  	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UDP-glucose pyrophosphorylase (UGP1) 
 UDP-glucose pyrophosphorylase (Ugp1) is the enzyme that catalyzes the 
production of UDP-glucose from UTP and glucose-1-phosphate (Figure 1-
4A)(32). In plants Ugp1 functions as a monomer, while in prokaryotes, slime 
molds and mammals it forms an octamer consisting of identical subunits(34). The 
high conservation of Ugp1 is due to the necessity of UDP-glucose as the glucosyl 
donor for many cellular reactions (Figure 1-4B). In yeast UDP-glucose is used as 
a glucosyl donor for β-glucan synthesis, glycogen synthesis, trehalose production 
and N-glycosylation of proteins within the endoplasmic reticulum. Ugp1 
enzymatic activity is essential in S. cerevisiae, which has complicated studies 
into its possible function aside from UDP-glucose synthesis. Ugp1 is 
phosphorylated on serine-11 by PAS kinase, which does not affect enzymatic 
activity. However phosphorylation does induce a conformational change(12). This 
conformational change in Ugp1 is associated with an increase in cell wall glucan 
production and a decrease in glycogen synthesis. To date Ugp1 is the only 
verified in vivo target of PAS kinase phosphorylation. 
 
Suppressor-Of-SIT4 deletion (SSD1) 
Suppressor-of-Sit4 deletion (SSD1) encodes a protein of 1250 amino 
acids. Ssd1 has an RNase H domain that is lacking critical catalytic residues for 
RNase activity and has not been shown to have RNase activity. Ssd1 can bind to 
RNA in vivo(10). SSD1 contains a common polymorphism at tyrosine 698,  




















Figure 1-4). Reaction catalyzed by Ugp1. Ugp1 catalyzes the formation of 
UDP-glucose from UTP and glucose-1-phosphate. (B) UDP-glucose can be 
used as a building block form synthesis of essential cellular components.  
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which causes a premature stop codon in some S. cerevisiae lab strains. It has 
been proposed that this premature stop codon has caused SSD1 to be over-
represented in yeast genetic screens and has thereby complicated the study of 
its proper cellular function, as shown in Table 1-1(1). Cells lacking SSD1 have an  
increase in cell wall mannan, chitin and decreased concentrations of glucans(35). 
These data indicate that Ssd1 may have a function in cell wall regulation. 
However, these results may just be a consequence of the RNA binding capacity 
of Ssd1.  
Ssd1 has been shown recently to bind mRNA and thereby suppress 
protein(10, 36). The RNA bound via Ssd1 primarily consisted of cell wall lysis 
enzymes. These enzymes are critical to facilitate cell wall remodeling that is 
required to accommodate cell division. However if these genes were expressed 
in a manner that is either temporally or spatially inappropriate it could be very 
detrimental. Ssd1 insures that these specific mRNAs are expressed in a spatially 
and temporally regulated manner. The inhibition of translation by Ssd1 is 
negatively regulated by Cbk1 phosphorylation. Cbk1 localizes to the bed neck 
and daughter cell, during mitosis. This localization ensures that the mRNAs 
responsible for expression of cell wall lysis genes are only expressed at the site 
of cell division. This regulation of expression may also be critical for daughter-cell 
specific protein expression. Interestingly, Ssd1 contains eight phosphorylation 
sites clustered at the N-terminus of the protein that contain the PAS kinase  




















Table 1-1). Genetic interactions of SSD1. Reported effects of addition of SSD1 are 
shown. Ts, suppresses a ts phenotype; sl, suppresses synthetic lethality between 
gene and (gene x); G, improves growth; L, suppresses lethality; D, causes death. 
Adapted from reference (1) 
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Gene Function interaction 
ARL1 Membrane trafficking ts 
BCK1 Protein kinase involved in cell wall integrity ts 
BEM2 GTPase-activating protein required for polarized cell growth ts 
BUL1 Protein that binds ubiquitin ligase ts 
CBK1 Protein kinase involved in cell morphogenesis  
CBC2 component of cap binding complex sl (sto1) 
CCR4 Transcriptional regulator of glucose-repressed and cell wall genes ts 
CDC28 Cylcin-dependent protein kinase ts 
CET1 mRNA capping enzyme ts 
CLN1/2 G1 cyclins G 
CYR1 Adenylate cyclase ts 
DHH1 ATP-dependent RNA helicase sl (elm1) 
ELM1 Serine/threonine protein kinase that regulates psuedohyphal growth sl (dhh1) 
HDF1 component of DNA end-joining repair pathway ts 
JNM1 Protein required for proper nuclear migration during mitosis ts 
LAS1 Essential gene required for bud formation and morphogenesis ts 
LUV1 Protein involved in protein sorting in the late golgi sl (rbl2) 
MEP1/2 Ammonium permeases involved in regulating psuedohyphal growth G 
MPT5 Protein required for high temperature growth and normal life span ts 
PAG1 Protein that functions with Cbk1p to regulate cell morphogenesis D 
PPH21/22 catalytic subunits of the protein phosphatase 2A ts 
PRP18 U5 snRNA-associated protein ts 
PRP22 Pre-mRNA splicing factor ts 
RBL2 Putative tubulin cofactor A sl (luv1) 
RDS3 Spliceosome component ts 
RLM1 transcription factor downstream of MPK1 ts 
RPC31 RNA polymerase III ts 
RPD3 Histone deacetylase component of the Rpd3-Sin3 complex sl (swi6) 
RPT4 Proteosome ATPase ts 
RRD1 Phosphotyrosyl phosphotase activator sl (rrd2) 
RRD2 Protein involved in rapamycin sensitivity sl(rrd1) 
SDS3 Component of the Rpd3-Sin3 histone deacetylase sl (swi6) 
SIN3 Component of the Rpd3-Sin3 histone deacetylase sl (swi6) 
SIT4 Phosphatase required for G1-S transition L 
SLC5 Unknown ts 
SLG1 Protein required for maintenance of cell wall integrity ts 
SLT2 MAP kinase that functions downstream of BCK1/SLK1 ts 
SLY1 Protein involved in vesicle trafficking ts 
SMC2 Subunit of condensing protein complex ts 
SMC4 Subunit of condensing protein complex ts 
SNP1 U1 snRNA-associated protein ts 
STO1 Component of cap-binding complex sl (cbc2) 
SWI4 Cell-cycle-specific transcription factor sl (mpt5) 
SWI6 Cell-cycle-specific transcription factor sl (mpt5) 
U5AI U5 snRNA ts 
YPT1 GTP-binding protein involved in the secretory pathway ts 
YPT6 GTP-binding protein involved in the secretory pathway ts 
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phosphorylation consensus sequence. Six of the eight sites have a histidine at 
the -5 position in relation to the phosphorylated residue, which is the preferred 
amino acid for PAS kinase phosphorylation. Preference for histidine at -5 is 
unusual and is only shared by Cbk1. These sites have been shown to be 
important for the regulation of Ssd1. If the eight sites (serine or threonine) are  
mutated to the nonphosphorylatable alanine, over-expression of this mutant is  
lethal. This seems to be due to a thickening of the cell wall, such that the cells 
can no longer divide. This is consistent with Ssd1 regulating the expression of 
cell wall lysis genes.  	  
ROM2-RHO1 
Rho1 is a small GTPase of the Rho/Rac subfamily of Ras-like GTPases. 
In the active state Rho1 is bound to GTP. The intrinsic GTPase activity of Rho1 is 
regulated by GTPase activating proteins (GAPs) Bem2, Sac7, Bag2 and Rdi1, 
which leads to hydrolyses of GTP to GDP (Figure 1-5)(37). GTP hydrolyses 
causes inactivation of Rho1. Guanine nucleotide exchange factors (GEFs) 
catalyze the exchange of GDP for GTP in order to activate Rho1 signaling(38). 
Active Rho1 mediates its effects on the cell through activation of downstream 
effectors(39-41). Rho1 activates protein kinase C (PKC), which leads to 
activation of the mitogen-activated protein kinase (MAPK) cascade composed of 
BCK1, MKK1/2 and MPK1.  Activation of this cascade controls actin cytoskeleton  











Figure 1-5). Schematic of Rho1 activation.  GTP-bound Rho1 is inactivated by 
GTPase activating proteins (GAP), which activates the intrinsic GTPase activity of 
Rho1. GDP-bound Rho1 is activated by guanine nucleotide exchange factors (GEF), 
which catalyzes the exchange of GDP for GTP.  GTP-bound Rho1 activates multiple 
downstream effectors that lead to actin polarization and cell wall synthesis. 
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organization as well as cell wall biogenesis genes. Rho1 also binds to and 
activates the integral plasma membrane protein Fks1, the enzyme responsible 
for the synthesis of β-1,3-glucan, to directly control cell wall biogenesis. Rho1 
also associates with Bni1, involved in cortical actin organization and Skn7, a two-
component system transcription factor that elicits an oxidative stress response. 
 Not all Rho1 effectors are activated in response to Rho1 activation. The  
downstream effectors that are activated by Rho1 depend, at least partially, on 
which Rho1 GEF is responsible for activation(41). There are three verified Rho1 
GEFs in S. cerevisiae: Rom1, Rom2 and Tus1. Tus1 and Rom2 are partially 
redundant in the context of TORC2 signaling. However it is still unclear exactly 
which downstream Rho1 effectors are essential for TORC2 function. It may be 
that TORC2 can preferentially activate specific Rho1 signaling pathways via 
differential GEF activation. TORC2 is able to activate both MAPK signaling and 
Fks1 function downstream of Rho1. Notably, it has been shown that an fks1Δ 
mutant partially suppresses a tor2ts (27). These data indicate that Fks1 is 
dispensable for TORC2 activity and that cell wall synthesis regulation is not an 
essential function of TORC2. 
 
Discovery of a novel signaling pathway 
 The tor2ts mutant can be suppressed by cell integrity stress, created 
chemically by treatment with detergent or cell wall perturbing agents (i.e., congo 
red) or genetically by deletion of genes involved in cell wall 
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production/maintenance. However the mechanism responsible for this 
suppression has never been elucidated. Understanding this pathway is important 
for understanding how the cell responds to stress and the signaling mechanisms 
that promote cell growth. In Chapter 2 we describe the discovery of a novel 
signaling pathway that can respond to cell stress to promote growth. This 
pathway is required for cell integrity stress to suppress the tor2ts mutant and 
involves the formation of a novel signaling complex that includes the PAS kinase 
phosphorylation dependent association of Ugp1, Rom2 and Ssd1 (Figure 1-6). 	  
 
Central control of energy homeostasis 
 In higher eukaryotes appetite and nutrient utilization are influenced via 
neuronal inputs. These responses are regulated in the brain, more specifically 
through the arcuate nucleus (ARC) of the hypothalamus(42). The ARC releases 
neuropeptides, which signal to the paraventricular nucleus (PVN), the 
dorsomedial nucleus (DMN) and the ventralmedial nucleus (VMN), which can 
directly modulate feeding behavior(43-45). Within the ARC there are two 
populations of neurons: orexigenic (appetite inducing) and anorexigenic (appetite 
inhibitory) neurons. The orexigenic population includes neuropeptide Y (NPY) 
and agouti-related protein (AgRP) expressing neurons. The anorexigenic 
population includes pro-opiomelanocortin (POMC, precursor of melanocyte-
stimulating hormone α-MSH) and cocaine and amphetamine-regulated transcript 
protein (CART) expressing neurons.  







Figure 1-6). Schematic of PAS kinase suppression of the tor2ts. PAS kinase 
phosphorylates Ugp1, which induces a translocation from the cytoplasm to the cell 
periphery. At the cell periphery P-Ugp1 nucleates the formation of a complex that 
includes Rom2 and Ssd1. Complex formation leads to activation of Rho1 and 
suppression of the tor2ts.  
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Feeding activates POMC neurons, which stimulates the release of α-MSH 
and CART. Both, α-MSH and CART, bind to the melanocortin receptor 4 (MC4R) 
within the PVN to inhibit feeding behavior. α-MSH release leads to inhibition of 
glucose secretion from the liver, which is critical to maintain blood glucose in a 
narrow physiological range and inhibits the release of orexigenic neuropeptides. 
Conversely, release of AgRP directly antagonizes the binding of α-MSH to MC4R 
contributing the opposing effects of NPY/AgRP and POMC neurons on energy 
homeostasis. NPY release from the ARC leads to an increase in feeding 
behavior, hepatic glucose production and lipogenesis. In order for the ARC to 
effectively regulate feeding behavior it must receive input from the whole body. 
The nutrient status of the body is conveyed to the ARC via secreted proteins from 
peripheral tissues.  
 
Endocrine regulation of energy homeostasis 
 In order for the central nervous system to appropriately regulate whole-
body metabolism and energy intake it must receive inputs from the peripheral 
tissues of the body, which is accomplished primarily through secreted hormones. 
These are inputs from peripheral tissues that impinge upon the hypothalamus 
and central control of energy homeostasis. As with any global metabolic 
regulation the system has to be able to effectively integrate signals from various 
sources of energy, including food intake, circulating nutrients and energy storage, 
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which is accomplished primarily through the gut, pancreas and adipose tissue, 
respectively.  
One endocrine organ that impinges on hypothalamic signaling is the 
pancreas. The pancreas responds to circulating blood glucose levels to release 
either insulin or glucagon into the blood stream. Under conditions of high 
circulating blood glucose concentrations the β-cells of the pancreas secrete 
insulin. Secretion of insulin from the pancreas is tightly coupled to an increase in 
intracellular ATP concentration(46). Insulin then binds to the insulin receptor (IR), 
which is expressed ubiquitously including neurons within the hypothalamus. 
Insulin release causes an increase in glucose uptake and utilization by peripheral 
tissues and suppresses gluconeogenesis within the liver(47). This allows the 
increase in blood glucose to be cleared via uptake within the peripheral tissue. 
Insulin also functions as a growth factor via promotion of amino acid uptake, 
protein synthesis and cell growth(48). Insulin acts within the hypothalamus to 
suppress energy intake via activation of the IR within the ARC(49). Insulin is a 
major regulator of dietary glucose utilization and energy homeostasis. 
When blood glucose levels fall, the α-cells within the pancreas secrete 
glucagon. Glucagon elicits a switch from glucose uptake and utilization to 
mobilization of energy stores(50). Within the liver, the switch in substrate 
utilization is also coupled to an increase in gluconeogenesis and glucose 
secretion in order to sustain blood glucose levels. This is essential for organs 
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such as the brain and red blood cells, which are heavily dependent on glucose 
for energy production. 
Adipose tissue is not only a storage depot for fat, but also an endocrine 
organ(51). White adipose tissue releases the anorectic hormone leptin. 
Circulating levels of leptin correlate positively with total body adiposity.  Leptin 
promotes satiety through activation of the leptin receptor within the 
hypothalamus. Leptin simultaneously binds to NPY/AgRP neurons to inhibit the 
release of orexigenic signals and POMC neurons to stimulate the release of 
anorectic neuropeptides. Peripheral tissues also express the leptin receptor, 
which when activated promotes fatty acid oxidation. Leptin receptor activation 
within the liver inhibits gluconeogenesis and glucose secretion.  
 White adipose tissue also releases adiponectin, another hormone. 
Circulating plasma adiponectin levels negatively correlate with fat mass. 
Adiponectin has been shown to function as an insulin sensitizer in genetic 
models of obesity, such as ob/ob mice. This is mediated through activation of the 
AMPK signaling network, which leads to an increase in fatty acid oxidation and 
glucose uptake by peripheral tissues(52). Adiponectin also modulates central 
control of feeding through the hypothalamus. Activation of the adiponectin 
receptor in the hypothalamus leads to a decrease in energy expenditure and 
increase in food intake through the NPY/AgRP expressing neurons(51). 
 The gut releases a several hormones with anorectic effects. These include 
cholecystokinin, glucagon-like pepride-1 (GLP-1), oxyntomodulin (OXM), 
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pancreatic polypeptide (PP), peptide tyrosine tryrosine (PYY) and islet amyloid 
peptide (IAP)(53-55). The mechanism by which each of these hormones elicits 
an effect has not been completely elucidated. However the postprandial 
expression and release of each of these hormones indicates that they are likely 
satiety signals. Many of these peptides affect gastric emptying and digestive 
enzyme release into the gut. GLP-1 is able to stimulate insulin release from the 
pancreas(56). These anorectic hormones slow digestion, increase nutrient 
absorption and elicit a satiety signal within the brain. However the mechanism of 
action within the hypothalamus has not been fully elucidated. 
 Ghrelin is the only known orexigenic peptide that is released by the gut 
and circulating levels increase before meals (57). The ghrelin receptor (GHS-R 
1a) is primarily expressed within the AgRP/NPY neurons and activation 
massively up-regulates expression of the neuropeptides NPY and AgRP(58).  
The increase in NPY/AgRP leads to an increase in food intake. Ghrelin has no 
direct effect on expression of the anorexigenic POMC mRNA. However it does 
appear to indirectly inhibit the firing of the POMC expressing neurons.  
  Interestingly, the intracellular signaling modalities that regulate feeding 
behavior within the brain are ubiquitously expressed within all tissue types(2, 3). 
The ancient intracellular nutrient responsive modalities are even found within the 
unicellular s. cerevisiae. Multicellular organismsʼ more complex mechanisms of 
regulation have been grafted onto these ancient nutrient regulation systems. 
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These cell-autonomous mechanisms of energy regulation will be briefly reviewed 
below. 
 
Cell autonomous signaling mechanisms 
 The endocrine system elicits its effects on the organism through 
intracellular activation of metabolic signaling pathways(5). Many of these 
intracellular signaling mechanisms are highly conserved through evolution(59).  
These mechanisms allow the cell to integrate whole body metabolism with the 
local microenvironment of the cell. The overall health of the organism is dictated 
by intracellular decisions that are made in response to extracellular inputs. 
Misregulation of these response mechanisms can lead to many pathological 
outcomes including obesity or cancer. Specifically, cell autonomous metabolic 
decisions are primarily guided by a few well-characterized signaling pathways. 
The master regulators of cellular metabolism are generally characterized by an 
ability to integrate multiple inputs and then propagate the output signal. Two of 
the best-characterized regulators of cellular energy status are TOR and AMPK, 
two highly conserved protein kinases(2, 3).  
A fundamental cellular requirement is that cells couple availability of 
nutrients to growth factor signaling in order to drive growth only when there are 
sufficient nutrients to undergo cell division. Under conditions of low ATP and high 
AMP, AMPK acts as an energy checkpoint within the cell to stop cell growth and 
activate ATP-producing cellular processes(7). AMPK is a highly conserved 
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heterotrimeric protein kinase complex that consists of one catalytic (α) subunit 
and two regulatory (β and γ) subunits. In mammals there are multiple paralogs of 
each subunit, which increases the heterogeneity of the AMPK complex allowing 
for variation in complex distribution and sensitivity. However the redundancy of 
the subunits has made study of AMPK on an organismal level difficult. The 
AMPKα1-/- AMPKα2-/- mice are embryonic lethal at 10.5 days postfertilization, 
indicating an essential role for AMPK in development. The AMPKα1-/- has no 
detectable metabolic phenotype, which could be due to redundancy with 
AMPKα2. AMPKα2-/- results in mild insulin resistance and impaired glucose  
tolerance that is associated with an insulin secretion defect(60, 61). This effect 
seems to be due to the role of AMPK in the autonomic nervous system because 
cells isolated from AMPKα2-/- function normally in isolation(61). The AMPKβ1 -/- 
mice have reduced food intake and adiposity on a high fat diet(62). These data 
generated from the knockout mice, which are complicated because of 
redundancy, indicate that AMPK is critical for normal energy homeostasis.  
In order to understand the role of AMPK in energy homeostasis cell culture 
systems and model organisms have provided a clear biochemical understanding 
of AMPK function. As intracellular AMP levels increase AMP binds directly to the 
tandem repeats of crystathionine-B-synthase domains of the γ-subunit(63). 
Binding of AMP is thought to prevent dephosphorylation of a critical activation 
loop threonine (Thr172) of the α-subunit. Phosphorylation of this threonine is 
absolutely required for activation of the kinase.  Activation of AMPK leads to 
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inhibition of glycogen synthesis, lipid synthesis and gluconeogenesis (Figure 1-
7)(2). This inhibition is coordinated with up-regulation of lipid oxidation, glycolysis, 
mitochondrial activity and mitochondrial biogenesis.  
Hepatic metabolism plays a central role in whole body energy 
homeostasis and is a major site for storage and distribution of glucose. AMPK 
activation, within the liver, induces a switch from lipid synthesis to lipid 
oxidation(64). The switch is mediated by phosphorylation and inhibition of Acetyl-
CoA carboxylase (ACC). Inhibition of ACC produces a drop in intracellular 
malonyl-CoA levels. Malonly-CoA is a precursor for fatty acid synthesis and is 
also a potent inhibitor of mitochondrial β-oxidation by inhibition of carnitine 
palmitoyltransferase (CPT1)(65). Within skeletal muscle AMPK promotes 
mitochondrial biogenesis at least in part through activation of the transcription 
factors PPAR-gamma coactivator (PGC-1α) and peroxisome proliferator-
activated receptor (PPAR-δ)(66). The animal knockout data taken together with 
the cell culture data indicate that AMPK plays a critical function in energy 
metabolism through effects on lipid oxidation, glycolysis and mitochondrial 
function. AMPK function is partially tissue specific. However AMPK activation 
universally leads to up-regulation of energy producing processes.  
Mammalian Target of Rapamycin (mTOR) is a conserved serine/threonine 
kinase that is a master regulator of cell size and growth(3). Similar to S. 
cerevisiae, mTOR forms two functionally distinct complexes, mTORC1 and 
mTORC2(67, 68). In mammals mTORC1 consists of four proteins: raptor  






Figure 1-7).  Overview of AMPK signaling in the hypothalamus and peripheral 
tissues. AMPK responds to a decrease in energy availability to stimulate energy 
production and inhibit energy consumption.  Adapted from reference (2) 
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(regulatory associated protein of mTOR), PRAS40, mLST8 and mTOR. Growth 
factors and nutrients both activate mTORC1. There are two well-characterized 
mTORC1 downstream targets: 4EBP1 and the p70 ribosomal S6 kinase 
(S6K)(69). Phosphorylation of 4EBP1 by mTORC1 suppresses 4EBP1ʼs 
inhibition of the translation initiation factor eIF4E (Figure 1-8)(70). 
Phosphorylation of 4EBP1 and S6K leads to an increase in protein translation, 
including expression of specific cell growth regulators such as HIF-1α and c-myc. 
S6K activation also controls lipid synthesis through post-transcriptional regulation 
of the sterol regulatory element-binding protein 1c (SREBP1c)(71). Chronic 
mTORC1 activation, as in the case of hyperglycemia, hyperlipidemia and 
hyperinsulinemia, lead to direct phosphorylation and degradation of components 
of insulin signaling(72). This negative feedback loop that suppresses insulin 
signaling might be responsible for some insulin resistance found in diabetics. 
The mouse knockout of mTOR is embryonic lethal(73). However S6K 
knockout mice, an effector of mTORC1 that acts to integrate nutrient and insulin 
signals, have several metabolic defects(72, 74). Specifically, the mice are 
hypoinsulinemic, glucose intolerant and have reduced β-cell mass. On a high fat 
diet (HFD), S6K-/- mice have an increase in circulating free fatty acids and 
glucose but they remain insulin sensitive. The insulin sensitivity appears to be 
due to a lack of the negative feedback loop from S6K to IRS1. The effect of the 
S6K-/- indicates that mTOR signaling is required to properly utilize nutrients.  
 
















Figure 1-8).  Overview of mTORC1 signaling. In response to nutrient replete conditions 
mTORC1 up-regulates anabolic processes and inhibits catabolic processes. Growth factor 
signaling also activates mTORC1, which drives an increase in cell size primarily through 
translation.  
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Identification and characterization of these two key metabolic kinases 
(AMPK, mTOR) have led to an increase in our understanding of growth and 
energy homeostatsis. This understanding has also produced novel treatments for 
a myriad of pathologies from obesity to cancer. Metformin has become a highly 
prescribed drug for many obesity related pathologies and is a potent activator of 
AMPK. Rapamycin(75) and other second generation drugs(76) are used for the 
treatment of some cancers as well as an immunosuppressant prior to organ 
transplantation(77). These drugs are selective inhibitors of mTORC1 signaling. 
As our understanding of the molecular events that occur within the cell increases, 
so does our ability to treat the pathologies that stem from malfunctions in that 
system. We have phenotypically characterized the mouse knockout of PAS 
kinase (PASK-/-) and shown that PASK is required for normal energy 
homeostasis. The PASK-/- mice are resistant to diet-induced obesity when 
challenged with a HFD and are hypermetabolic as measured by indirect 
calrimetry. On a HFD the PASK-/- are resistant to hepatosteatosis. The 
hypermetabolic phenotype of the PASK deficient mice can be replicated in a cell 
culture model. These data indicate that PASK functions in a cell autonomous 
mechanism to regulate energy homeostasis.  	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Abstract 
 
In a high copy suppressor screen of a mutant of the S. cerevisiae Target 
of Rapamycin 2 (tor2) gene, we isolated PSK1 and PSK2, paralogous yeast 
genes encoding two serine/threonine kinases, referred together as PAS kinase. 
We also show that post-translational activation of PAS kinase, either by cell 
integrity stress or growth on nonfermentative carbon sources, suppresses the 
tor2 mutation.  Suppression of the tor2 mutant by PAS kinase activation requires 
phosphorylation of the metabolic enzyme Ugp1 on serine-11. Ugp1 
phosphorylation nucleates the formation of a complex that induces Rho1 
activation.  In addition to phospho-Ugp1, this complex contains Rom2, a Rho1 
guanine nucleotide exchange factor, and Ssd1, a poorly characterized RNA 
binding protein.  Activation of PAS kinase-dependent Ugp1 phosphorylation, 
therefore, promotes two processes that are required for cell growth and stress 
resistance.  First, as shown previously, Ugp1 phosphorylation leads to the 
synthesis of cell wall material through an alteration in glucose partitioning.  
Second, through the formation of a signaling complex, it leads to polarized cell 
growth through Rho1 activation This complex potentially integrates the metabolic 
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Introduction 
 
Organisms must monitor their environment in order to respond 
appropriately to changes in nutrient levels, temperature, and toxins. One of the 
most critical decisions made by organisms is whether to stimulate or arrest 
growth given the current environmental situation. In multicellular organisms, this 
decision depends upon inputs from neighboring cells, hormonal cues and 
neuronal signaling. In this context making the wrong growth decision at a cellular 
level can lead to pathological consequences, including cancer.  Cells from 
multicellular organisms also have autonomous mechanisms to measure nutrient 
availability, which integrated with extrinsic signals, enables making appropriate 
growth decisions.   
Two evolutionarily conserved kinases that participate in this sensing and 
response are the 5ʼ-AMP-activated protein kinase (AMPK) (1) and the Target of 
Rapamycin (TOR)(2, 3). AMPK is activated when intracellular energy in the form 
of ATP is depleted and promotes a switch from ATP consumption to ATP 
production(4). One primary aspect of this switch is a cessation of cell growth and 
division. The TOR protein kinase is activated under nutrient replete conditions 
and leads to an increase in protein translation and cell growth (2, 5). As such, it 
has been called a master regulator of cell and organismal size in most 
organisms.  
The S. cerevisiae genome contains two closely related TOR genes, TOR1 
and TOR2. The protein products of these two genes function in two distinct 
protein complexes termed TOR complex 1 (TORC1) and TOR complex 2 
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(TORC2)(6-8). TORC1, which contains either Tor1 or Tor2 as well as Kog1, 
Tco89 and Lst8, regulates protein synthesis and cell size in response to nutrient 
availability. TORC1 function is sensitive to inhibition by rapamycin. TORC2, 
which contains Tor2 (but not Tor1), Avo1, Avo2, Avo3, Bit61 and Lst8, is 
essential for cell division and cell cycle-dependent polarization of the actin 
cytoskeleton (9-11). TORC2 function is not directly sensitive to rapamycin. 
TORC2 regulates polarized cell growth at least partially through activation of the 
small GTPase Rho1 (12). Rho1 regulates many downstream signaling pathways 
including Protein Kinase C (Pkc1)-mediated activation of MAPK signaling, 
activation of cell wall synthesis via Fks1 and polarization of the actin cytoskeleton 
to enable cell growth and division (13-16). As stated in Chapter 1 strains 
harboring a temperature sensitive allele of TOR2 (tor2ts) arrest growth at the 
restrictive temperature (37° C) due to lack of TORC2 activity and decreased 
activation of Rho1(6). The lethality caused by a tor2ts mutant can be suppressed 
by proteins that activate Rho1, or growth nonfermentative carbon sources but not 
nonfermentable carbon sources. Unexpectedly, cell integrity stress can also 
suppress the tor2ts phenotype (17). However the cellular mechanism connecting 
nonfermentative carbon sources, cell wall stress and suppression of the tor2ts 
remains unresolved. These data suggest the presence of signaling networks that 
can integrate input from cell integrity and metabolic signals to control cell growth.    
The recent past has seen many advances in our understanding of the 
diversity of inputs that are recognized by cell autonomous nutrient sensors and of 
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those sensors themselves.  One advance was the discovery and initial 
characterization of PAS kinase, which is required for normal energy balance in 
organisms from S. cerevisiae to mice (18, 19). However, the mechanisms 
whereby PAS kinase signaling integrates into broader cellular signaling networks 
have remained undiscovered. The S. cerevisiae genome contains two closely 
related and partially redundant PAS kinase paralogs, PSK1 and PSK2 (referred 
to together as PAS kinase). Cell integrity stress activates PAS kinase via the 
WSC family of cell membrane sensors (20). Cellular nutrient status can also 
activate PAS kinase through an interaction with the Snf1/AMPK signaling 
pathway.  Psk1 and Psk2 both phosphorylate serine-11 of Ugp1, the enzyme 
responsible for the synthesis of UDP-glucose, which is the glucose donor for 
glycogen and cell wall glucan production. Surprisingly, phosphorylation at serine-
11 does not affect the enzymatic activity of Ugp1, but rather the destination of the 
glucose moiety from UDP-glucose (21). In the unphosphorylated state, Ugp1 
synthesizes UDP-glucose that is used preferentially for the synthesis of glycogen. 
In the phosphorylated state, Ugp1 produces UDP-glucose that is partitioned 
preferentially toward production of cell wall glucans. Therefore, a PAS kinase null 
strain (psk1∆ psk2∆) exhibits a dramatic increase in glycogen content at the 
expense of cell wall glucan, indicating an inability to properly regulate glucose 
flux. All PAS kinase mutant phenotypes are completely phenocopied by mutating 
Ugp1 serine-11 to alanine (Ugp1-S11A), which prevents Ugp1 phosphorylation. 
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This indicates that the effects of PAS kinase on glucose partitioning are primarily 
mediated through Ugp1 phosphorylation.  
In a screen for multicopy suppressors of the lethality of a tor2ts mutant, we 
discovered both PSK1 and PSK2. We found that the signaling mechanism by 
which PAS kinase suppresses the tor2ts requires phosphorylation of Ugp1. We 
show that phosphorylated Ugp1 enables the formation of a signaling complex, 
containing phosphorylated Ugp1, Ssd1 and Rom2, which leads to the activation 
of Rho1. The activation of Rho1, in response to PAS kinase dependent 
phosphorylation of Ugp1, stimulates cell survival and growth. Thus, we describe 
a signaling pathway by which PAS kinase signals for cell growth in coordination 
with its previously described progrowth effects on glucose partitioning.  
 
Results 
PAS kinase is both necessary and sufficient  
for suppression of the tor2ts  
Due to its role in enabling cell growth and division as a component of 
TORC2, Tor2 is essential for viability (6). Because a tor2 deletion mutant is 
inviable, we have utilized a temperature-sensitive tor2ts mutant to conduct a high 
copy suppressor screen for novel genes that enable suppression of the lethality 
caused by a tor2ts. This screen should reveal genes that are downstream of Tor2 
or genes that can activate similar growth pathways, but do so independently of 
Tor2.  We used a 2-micron library constructed from the S. cerevisiae genome to 
	   50	  
discover genomic fragments that could suppress the tor2ts. We recovered 
genomic fragments that contained RHO2, PSK1 and PSK2, all of which 
suppressed the growth defect of the tor2ts strain at the restrictive temperature 
(Figure 2-1A). Overexpression of RHO2 is very likely to suppress the tor2ts by 
functioning analogous in a manner analogous to RHO1 (12), but it was unclear 
how PSK1 or PSK2 could suppress. To determine if PAS kinase alone is 
sufficient to suppress the tor2ts, we assayed suppression by the isolated, full-
length PSK1 or PSK2 expressed from their endogenous promoters. 
Overexpression of either PSK1 or PSK2 was sufficient to support growth of the 
tor2ts at the restrictive temperature. This suppression requires kinase activity as a 
PSK2 kinase domain mutant (K870R) was completely unable to promote growth 
of the tor2ts mutant (Figure 2-1B). As with the other functions of PAS kinase (20), 
PSK2 might be the predominant gene in this signaling pathway given its more 
pronounced suppression relative to PSK1.  
Given that all of the known psk1Δ psk2Δ phenotypes are completely 
phenocopied by the UGP1-S11A allele, we wanted to test whether Ugp1 
phosphorylation is necessary for suppression. In the presence of the 
unphosphorylatable Ugp1-S11A protein neither PSK1 nor PSK2 could suppress 
















Figure 2-1). PAS kinase-dependent suppression of the tor2ts requires 
kinase activity and Ugp1 phosphorylation. Strains of the indicated genotype 
were grown to saturation and serially diluted in water.  These diluted samples 
were then spotted onto synthetic minimal media lacking uracil and incubated at 
the indicated temperature for two days. (A) Plasmids that contain all or part of 
RHO2, PSK1 and PSK2 were recovered from a high copy suppressor screen of 
the tor2ts (B) PSK1 and PSK2 are able to suppress the tor2ts which is dependent 
on kinase activity. High copy plasmids that contain full length PSK1, PSK2 or 
PSK2 kinase dead (K870R) were expressed from their endogenous promoters 
and assayed for an ability to suppress the tor2ts. (C) PAS kinase-dependent 
suppression requires Ugp1 phosphorylation on serine-11.  Neither PSK1 nor 
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dependent suppression (Figure 2-1C). We have previously shown that S11E and 
S11D mutants of Ugp1 do not mimic the phosphorylated state, but rather mimic 
constitutively unphosphorylated state. These acidic mutations showed a similar 
effect in tor2ts suppression. Specifically, they fail to enable suppression by PSK2 
overexpression (data not shown). As a result, we remain unable to determine the 
sufficiency of Ugp1 phosphorylation for tor2ts suppression.  
 
PAS kinase activation suppresses the tor2ts  
and increases Ugp1 phosphorylation  
The tor2ts mutant is unable to grow at high temperature (37° C) 
presumably because of decreased functional TORC2. The tor2ts mutant can be 
suppressed by supplementation of 1 M sorbitol in the media (see supporting 
information for this Chapter)(6), indicating that the lethality of the tor2ts is due to 
cell wall instability and cell lysis.  In light of this observation, it is surprising that 
treatment with agents that destabilize the cell membrane or cell wall (e.g., 
calcofluor white, congo red, SDS, Tween) suppress rather than exacerbate the 
tor2ts mutant phenotype (17). The mechanism by which cell integrity stress 
suppresses the tor2ts is unknown, but we speculated that PAS kinase might be 
involved because it is activated by cell integrity stress (20) and suppresses the 
tor2ts when over-expressed. Therefore, we tested the necessity of PAS kinase for 
suppression of the tor2ts by cell integrity stress. Given that Psk2 responds more 
robustly to cell integrity stress and that Psk2 over-expression more fully 
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suppresses the tor2ts when compared to Psk1, we focused primarily on the role 
of PSK2 in these studies. As expected, the tor2ts phenotype was suppressed by 
the addition of 0.005% SDS to the media (Figure 2-2A).  The tor2ts strain also 
containing the psk2Δ mutation, however, was not able to grow on the SDS 
supplemented media (Figure 2-2A).  Consistent with the known role of Psk2 in 
cell integrity stress response, the psk2Δ mutant showed a modest growth defect 
in the on SDS supplemented media. As with PAS kinase over-expression, PAS 
kinase-dependent suppression via cell integrity stress is dependent on 
phosphorylation of Ugp1 at serine-11 (Figure 2-2A). Therefore, in the presence of 
normal Tor2 signaling, Psk2 activation is not required for viability under cell 
integrity stress, but becomes essential upon Tor2 inactivation. Thus, activation of 
PAS kinase via two independent mechanisms, cell integrity stress and over-
expression, enables suppression of the tor2ts mutant phenotype.    
In addition to cell integrity stress, we have previously shown that PAS 
kinase is activated by growth on nonfermentative carbon sources(20). Given that 
either PAS kinase over-expression or activation in response to cell integrity 
stress suppresses the tor2ts, we asked whether other PAS kinase activating 
stimuli could likewise suppress the phenotype. As in Figure 2-2B, the tor2ts 
phenotype was suppressed by growth on either nonfermentative carbon source, 
raffinose or galactose, both of which cause PAS kinase activation. Deletion of 
PSK2 or the presence of Ugp1-S11A, however, attenuates this phenotype 
suppression.  Taken together, we have shown that three independent means of  
	   55	  
 
Figure 2-2). Activation of PAS kinase by either SDS or nonfermentative 
carbon sources suppresses the tor2ts. Strains of the indicated genotype were 
grown to saturation and serially diluted in water. The dilutions were then plated 
onto minimal glucose media lacking uracil unless otherwise indicated. (A) 
Suppression of the tor2ts via SDS is dependent on PAS kinase and Ugp1 
phosphorylation. Strains were grown to saturation and then serially diluted onto 
YPA media supplemented with 0.005% SDS.  
(B) Suppression of the tor2ts via growth on nonfermentative carbon sources is 
dependent on PAS kinase and Ugp1 phosphorylation. Strains were grown to 
saturation and then serially diluted on the indicated carbon source. (C) PAS 
kinase activation via over-expression, cell integrity stress (SDS, 37˚C) or non-
fermentative carbon sources (raffinose, galactose) increase Ugp1 
phosphorylation. Western blot is one representative experiment and bar graph is 
the average of four experiments.  
Wild-type strain was grown to saturation then back diluted to an OD600 ~0.2 in 
indicated media. SDS or heat shock treatment for 3 hours were grown in YPAD 
media.  PSK2 over-expression culture was grown in SD-ura and was incubated 













	   56	  















YPAD • II ' •• 
••• <e(!1 • ••• t? ••• ~ 
. ~S.~ ••.• t§S; • •• ~,tp 
.... ~ .. ' .. ~ 
..... , ~ . 
• ~ 'i':,~~ 
~ $ ~~; 
(j) ~ ,t~ " 






~ ,a. ,\,;:<0 " ,., ., \ ~. ' . 
. ~ 
1 1 
.~ t~ ' -" 
8' • . 
.:~ " 
• P-Ugp l /Pgk 
gp l /Ugp l . p-U 
U 
	   57	  
stress or nonfermentative carbon sources, all cause suppression of the tor2ts 
phenotype.  
Three distinct conditions that are expected to cause increased PAS kinase 
activity suppress the tor2ts. Activated PAS kinase phosphorylates Ugp1 at serine-
11, which leads to an increase in the production cell wall glucan. In order to 
confirm that these suppressing conditions actually do lead to an increase in Ugp1 
phosphorylation we performed immunoblots using an antibody specific for 
phospho(Ser11)-Ugp1. As seen in Figure 2-2C, each of these three conditions, 
overexpression of PSK1 or PSK2, cell integrity stress or nonfermentative carbon 
sources, also lead to an increase in Ugp1 phosphorylation. Together, these data 
suggest that activation of PAS kinase is sufficient to suppress the tor2ts and 
suppression requires Ugp1 phosphorylation.  
 
SSD1 is required for the tor2ts suppression  
by PAS kinase  
During the course of our studies of the suppression of the tor2ts phenotype by 
PAS kinase, which to this point were all conducted in the JK9 strain background, 
we made the surprising observation that PAS kinase was completely unable to 
suppress the tor2ts in the W303 strain background (Figure 2-3A-right panel). We 
reasoned that determining the key difference between the JK9 and W303 strains 
should provide insight into the genetic pathway underlying PAS kinase-
dependent suppression. To uncover the genetic basis for this distinction, we took  








Figure 2-3). SSD1 is required for PAS kinase to suppress the tor2ts. 
Strains were grown to saturation in selective media. The strains were then 
serially diluted in water; dilutions were then plated on minimal glucose media 
lacking uracil or uracil and methionine.  (A) SSD1v is required for PAS kinase to 
suppress the tor2ts.  The deletion was made in the Jk9 strain and the wild-type 
copy was expressed in the W303 strain from its endogenous promoter on a CEN 
plasmid. Strains were grown at 37˚ C for 3 days (B) nonphosphorylatable (Ssd1-
8A) or phosphomimetic (Ssd1-8D, Ssd1-8E) Ssd1 do not affect PAS kinase-
dependent suppression. Ssd1-8A/8D/8E were expressed from a 2-micron 
plasmid with a minimal CYC1 promoter. (C) Ssd1 associates with Ugp1 in a 
phosphorylation-dependent manner with a peak of association at 3 hours of heat 
shock at 37˚ C. Ssd1-HA was expressed from its endogenous promoter on a 
CEN plasmid. The tor2ts strain expressing Ssd1-HA was grown on synthetic 
glucose media lacking uracil to log phase. Crude cell lysates were then subjected 
to immunoprecipitation using anti-HA conjugated agarose beads. Strains were 
heat shocked at 37˚ C for 3 hours unless otherwise indicated. Ssd1 was detected 
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a candidate gene approach by examining known polymorphisms that vary 
between the two strains. Many laboratory S. cerevisiae strains have a mutation 
(ssd1d) that causes a premature stop codon in the SSD1 gene (22). SSD1 has 
been implicated genetically in many different cellular functions, but the 
biochemical function of Ssd1 has remained elusive (23-32). It has homology to 
the RNase II family of enzymes, but it lacks residues that are critical for catalytic 
activity.  Clues of Ssd1 biochemical function have come from recent studies 
showing that Ssd1 controls post-transcriptional gene expression through direct 
RNA binding (24, 33).  
The W303 strain contains the nonfunctional ssd1d allele, while JK9 
contains wild-type SSD1.  To determine whether this mutation is the key 
difference preventing suppression of the tor2ts by PAS kinase activation in the 
W303 strain, we complemented the ssd1d mutation with a plasmid containing the 
wild-type SSD1 gene. When wild-type SSD1 is provided, PAS kinase is now able 
to suppress the tor2ts phenotype in the W303 strain background (Figure 2-3A). 
Conversely, deletion of the wild-type copy of SSD1 in the JK9 strain prevents 
PAS kinase suppression of the tor2ts defect. These data indicate that SSD1 is 
necessary for PAS kinase to suppress the tor2ts and is epistatic to PAS kinase.  
Previously it has been shown that the function of Ssd1 in post-
transcriptional gene regulation is regulated via phosphorylation at eight N-
terminal sites(24). Six of these important phosphorylation sites are a perfect 
match for the PAS kinase consensus phosphorylation motif (HXRXX[S/T])(34). 
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 While Ugp1 phosphorylation is required for the PAS kinase-dependent tor2ts 
suppression, we wanted to experimentally determine whether Ssd1 
phosphorylation at these sites might also play a role.  Mutants of Ssd1 wherein 
the 8 phosphorylatable residues are mutated to alanine (Ssd1-8A) or a 
phosphomimetic amino acid (Ssd1-8D, Ssd1-8E) were generated. Over-
expression of unphosphorylatable Ssd1 was previously observed to cause 
toxicity (24), which was shown to be due to its role in gene expression.  As 
expected, we also observed that overexpression of Ssd1-8A caused toxicity, 
which was not observed when Ssd1 was either phosphorylatable at these sites or 
contained phosphomimetic substitutions (see Supporting Information for this 
Chapter). All of these SSD1 mutants, like the wild-type, enabled suppression of 
the tor2ts phenotype when expressed at endogenous levels (Figure 2-3B). These 
data indicate that phosphorylation of Ssd1 at these eight sites does not play a 
significant role in PAS kinase-dependent suppression of the tor2ts phenotype.  
This suggests that the role of Ssd1 in tor2ts suppression is distinct from its role in 
post-transcriptional regulation of gene expression. 
 
Ugp1 and Ssd1 physically interact in a  
phosphorylation-dependent manner  
We have previously described the likely mechanism whereby Ugp1 
phosphorylation controls glucose partitioning (21), specifically through the 
localization of Ugp1 to the cell periphery where its UDP-glucose product is 
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preferentially used for cell wall glucan synthesis.  How Ugp1 phosphorylation 
enables suppression of the tor2ts phenotype and why Ssd1 is required for this 
effect was not known.  We speculated that these two proteins might physically 
interact to nucleate a novel signaling complex. We expressed a C-terminally HA-
tagged Ssd1 at endogenous levels (native promoter/CEN plasmid) and tested for 
a possible interaction with Ugp1. Because Ugp1 phosphorylation was critical in 
the tor2ts strain at 37°C, we performed the co-immunoprecipitations under these 
conditions. As shown in Figure 2-3C, immunoprecipitation of Ssd1-HA also pulls 
down wild-type Ugp1. Ugp1 is an abundant protein and control 
immunoprecipitations often show trace levels of Ugp1, but specific interactions 
can be detected above this background.  We would expect this interaction to be 
dependent upon Ugp1 phosphorylation and tested that by co-
immunoprecipitation in a strain expressing the S11A mutant of Ugp1 from the 
endogenous locus.  Unlike the wild-type, we detected no interaction of the S11A 
mutant of Ugp1 with Ssd1-HA under any condition (Figure 2-3C). Because of the 
various other cellular roles that both Ugp1 and Ssd1 play in both growth and 
stress response, we wanted to determine if this association was dynamically 
regulated in response to a temperature increase. We tested the interaction in 
cultures grown at 37° C for 0, 3 and 5 hours (Figure 2-3C). Complex formation is 
enhanced in response to the temperature shift, but it returns to basal levels after 
5 hours at 37° C. These data taken together indicate that Ssd1 and Ugp1 form a 
heat stress-responsive complex that is dependent upon Ugp1 phosphorylation.  
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The tor2ts suppression effect of Ugp1  
phosphorylation is independent of  
glucose partitioning  
One of the lethal defects of the tor2ts mutant is instability of the cell wall as 
evidenced by the fact that it can be rescued by supplementation with the osmotic 
stabilizer sorbitol (6)(see Supporting Information for this Chapter).  Also, we have 
previously shown that phosphorylation of Ugp1 promotes increased cell wall 
glucan production at the expense of glycogen synthesis, with the effect of 
increased cell wall stability (21).  We have shown herein that phosphorylation of 
Ugp1 also causes suppression of the tor2ts mutant phenotype.  Taken together, 
these data led to the possibility that suppression of the tor2ts via PAS kinase 
overexpression or activation was simply due to glucose partitioning being altered 
in favor of cell wall glucan production.  Alternatively, Ugp1 might have a distinct 
phosphorylation-dependent role in cellular signaling that enables tor2ts 
suppression. This question cannot be answered directly as an inactive mutant of 
Ugp1 does not enable viability of a ugp1Δ strain, due to the essential role of 
Ugp1 in producing UDP-glucose (35).  We have conducted two experiments, 
however, that suggest that the tor2ts suppression role of Ugp1 is distinct from its 
role in glucose partitioning.  First, we have previously shown that overexpression 
of phosphoglucomutase-2 (PGM2) is sufficient to suppress a growth defect 
caused by loss of Ugp1 phosphorylation(19). Pgm2 is the enzyme responsible for 
the conversion of glucose-6-phosphate to glucose-1-phosphate, which is the 
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glucose donor for UDP-glucose synthesis by Ugp1.  When it is overexpressed, 
the increased UDP-glucose synthesis enables cell wall production and 
stabilization, even in the absence of Ugp1 phosphorylation (36).  If cell wall 
glucan synthesis were sufficient for tor2ts suppression, PGM2 overexpression 
should suppress.  As shown in Figure 2-4A, however, PGM2 overexpression had 
no effect on the temperature sensitivity of the tor2ts mutant. 
Second, if Ugp1 phosphorylation regulates glucose partitioning and tor2ts 
suppression through the same mechanism, then these two functions should be 
equally dependent upon SSD1.  We have previously shown that tor2ts 
suppression by Psk2 overexpression is completely dependent upon SSD1.  To 
determine whether PAS kinase-dependent regulation of glucose partitioning was 
dependent upon SSD1, we measured glycogen levels in wild-type and psk1Δ 
psk2Δ mutants in both the JK9 and W303 backgrounds both with and without 
SSD1. Our lab has shown previously that the psk1Δ psk2Δ exhibits glycogen 
levels that are dramatically higher than wild-type levels, concomitant with a 
decrease in cell wall production (21). The fold increase in glycogen content in the 
psk1Δ psk2Δ mutant relative to wild-type was not significantly different in either 
the JK9 or the W303 strain with or without functional SSD1 (Figure 2-4B). While 
the effects of PAS kinase deletion were identical in each genetic condition, there 
was an overall decrease in glycogen content in the JK9 strain with SSD1. This 
must be due to a genetic interaction between SSD1 and a gene other than PAS 
kinase that differs between the two strains.  
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Figure 2-4). The metabolic function of Ugp1 is separable from its signaling 
role. (A) PGM2 over-expression, which increases Ugp1 substrate availability, is 
not able to suppress the tor2ts. Strains were grown to saturation and then serially 
diluted in water. The dilutions were incubated at the indicated temperature for 2 
days. (B) SSD1 is not required for PAS kinase to regulate glycogen storage. Fold 
change between Wt and psk1∆psk2∆ for each SSD1 genotype is indicated above 
bars. Indicated strains were grown at 30˚ C to an OD600 ~1.0 and were harvested 
by centrifugation. The strains were assayed for glycogen content as described. 
(C) Deletion of SSD1 from the Jk9 strain results in a decrease in Ugp1 
phosphorylation. Quantification of four individual experiments is represented on 
the bar graph below a representative blot. P-Ugp1 signal was normalized to total 
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These data, taken together with the PGM2 data, suggest that there is a 
bifurcation in the PAS kinase pathway at the point of Ugp1 phosphorylation. 
Suppression of the tor2ts via phosphorylation of Ugp1 requires Ssd1. However, 
the ability of Ugp1 phosphorylation to enact the switch from production of UDP-
glucose for glycogen to use in cell wall glucans is independent of Ssd1.  These 
data would indicate that Ssd1 is not required for Ugp1 phosphorylation but may 
be necessary downstream of phosphorylation for the signaling function of Ugp1. 
Consistent with this observation, PAS kinase-dependent phosphorylation of Ugp1 
still responds to heat shock in the absence of Ssd1 (Figure 2-4C).  However, the 
ssd1Δ consistently has a decrease in total phospho-Ugp1. These data indicate 
that Ssd1 is not required for Ugp1 phosphorylation in response to PAS kinase 
activation, but it may be required to fully stabilize the phosphorylated form.  SSD1 
appears to be epistatic to Ugp1 phosphorylation, however, as SSD1 
overexpression is not sufficient to suppress the tor2ts (data not shown).  
 
PAS kinase suppression causes Rom2- 
dependent Rho1 activation  
Tor2 mediates the majority of its effects on cell growth and actin 
reorganization through activation of the small GTPase Rho1(37). Rho1 controls 
activation of the MAP kinase pathway, cortical actin polarization, cell wall 
synthesis and budding(14-16). Because of the critical role of Rho1 in mediating 
the effects of Tor2 activation on growth, we postulated that the ability of PAS 
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kinase to suppress the tor2ts might also be dependent on Rho1 activation, which 
is usually caused by guanine nucleotide exchange factors (GEFs). The S. 
cerevisiae genome encodes three GEFs for Rho1, ROM1, ROM2 and TUS1(38, 
39). To determine whether Rho1 activation by one of these GEFs was required 
for suppression of the tor2ts by PAS kinase, we examined suppression in strains 
each lacking one GEF.  While deletion of ROM1 and TUS1 had no effect on PAS 
kinase-dependent tor2ts suppression (see Supporting Information for this 
Chapter), it was completely abolished by deletion of ROM2 (Figure 2-5A).  
Because Rom2, like Ssd1, is required for suppression and Ssd1 physically 
interacts with Ugp1, we wanted to determine whether Rom2 might also be a 
component of this complex. A FLAG-tagged Rom2 protein expressed from the 
endogenous ROM2 locus precipitated wild-type Ugp1 (Figure 2-5B).  As with 
Ssd1, however, we detected no interaction between Rom2 and an S11A mutant 
of Ugp1 (Figure 2-5B).  
Because of the dynamic nature of the Ssd1-Ugp1 interaction in response 
to high temperature, we examined the kinetics of the Rom2-Ugp1 interaction. The 
kinetics of the association between Rom2 and Ugp1 are very similar to Ssd1 and 
Ugp1. The degree of association peaks at about 3 hours at 37° C, and the 
interaction returns to or below baseline by 5 hours (Figure 2-5C). However, unlike 
Ssd1, Rom2 total protein levels markedly decrease after 5 hours at 37° C.  To 
more systematically assess protein abundance, we grew cultures at 37° C and 




Figure 2-5). Rom2 is required for PAS kinase-dependent suppression and forms a 
complex with Ugp1. (A) Rom2 is necessary for PSK2 over-expression to suppress the 
tor2ts.   Indicated strains were grown to stationary phase and then serially diluted in 
water. Dilutions were then spotted onto synthetic medium lacking uracil and grown at 
indicated temperature for 2 days.  (B) Rom2 interacts with Ugp1 in a phosphorylation-
dependent manner. Strains containing Rom2-FLAG at the endogenous locus with or 
without the Ugp1-S11A allele were grown to log phase and then subjected to anti-
FLAG immunoprecipitation. (C) Rom2 interacts with Ugp1 in response to heat shock. 
Immunoprecipitations were performed on a Rom2-FLAG strain using anti-FLAG beads 
and blotted for Ugp1.  (D) PSK2 over-expression leads to increased Rho1 activity. 
Strains were grown to mid-log phase and GTP-bound Rho1 was immunoprecipitated 
with RBD beads. Biological replicates were loaded in adjacent lanes. 
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harvested samples every hour for 7 hours. We then blotted for Rom2, Ugp1, and 
Ssd1 to determine if there was a decrease in protein levels for any of them over 
the course of the heat shock. Rom2 protein levels decrease significantly after 
about 4 hours at 37° C (see Supporting Information for this Chapter). Ssd1 levels 
decrease similarly after about 4 hours. Ugp1 levels remain stable over the course 
of the heat shock treatment, but Ugp1 phosphorylation peaks after 1-2 hours at 
37°C and then gradually decreases over the remainder of the time-course (see 
Supporting Information for this Chapter) These data taken together suggest that 
Ugp1-Ssd1-Rom2 form a dynamic complex in response to Ugp1 phosphorylation. 
This complex is likely the signaling complex that enables tor2ts suppression by 
PAS kinase activation.    
The majority of the effects of TORC2 are mediated via activation of Rho1 
through one of its GEFs (12, 37).  As PAS kinase suppression of the tor2ts 
requires ROM2 and Rom2 interacts with Ssd1 and phospho-Ugp1, we 
speculated that this Rom2 complex promotes Rho1 activation and thereby 
bypasses the requirement for Tor2 activity.  Therefore, we determined whether 
PSK2 overexpression was sufficient to activate Rho1 in the tor2ts mutant strain.  
Levels of GTP-bound (active) Rho1 were determined by isolation with RBD-
conjugated beads and Western blot (40, 41).  As expected, the tor2ts has 
attenuated levels of active Rho1 when compared to wild-type cells (Figure 2-5D). 
Overexpression of PSK2 in the tor2ts mutant, however, increased the levels of 
GTP-bound Rho1 to roughly wild type levels.  Therefore, PAS kinase 
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overexpression causes Ugp1 phosphorylation, the formation of a 
Ugp1/Ssd1/Rom2 complex and the activation of Rho1.  Through this pathway, 
PAS kinase enables suppression of the tor2ts mutant phenotype and promotes 
cell growth in response to nonideal conditions.  
 
Discussion 
Activation of PAS kinase, via over-expression, cell integrity stress or 
growth on nonfermentative carbon sources, increases Ugp1 phosphorylation and 
enables suppression of the tor2ts. Ugp1 phosphorylation nucleates the formation 
of a very unusual signaling complex, specifically a complex that contains a 
metabolic enzyme (Ugp1), a degenerate RNase (Ssd1) and a Rho1 GEF (Rom2) 
and possibly other proteins.  Interestingly, the roles of Ugp1 and Ssd1 within this 
complex appear to be separable from their defined roles in glucose utilization (20, 
21) and translational repression (24, 33), respectively. We found that this 
complex appears to activate Rho1, thereby playing an important role in cellular 
growth control. 
 As relates to its Rho1 activation function, the proximal active component of 
this complex is likely to be Rom2, due to its known role as a Rho1 guanine 
nucleotide exchange factor (GEF) (17). Rho1 has at least four downstream 
effectors. It binds to and activates Pkc1 (37), which activates the MAP kinase 
signaling cascade. Rho1 activates cell wall synthesis by binding to and activating 
Fks1, the β-1,3-glucan synthase (15). Finally, Rho1 interacts with Bni1, a formin 
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family member (16) and Skn7 a two-component signaling factor (42).  
Interestingly activation of Rho1 does not always produce equivalent activation of 
all of the downstream effectors. Instead Rho1 activation can preferentially 
activate specific downstream effectors, which is at least partially dependent on 
the activating GEF. PAS kinase-dependent suppression of the tor2ts appears to 
function exclusively through Rom2, and not Rom1 or Tus1, two other verified 
Rho1 GEFs. Dependence on Rom2 is probably due to its unique ability to 
assemble in the Ugp1-Ssd1 complex. The tor2ts strain arrests growth with a 
disorganized actin cytoskeleton (37), which can be suppressed by over-
expression of Pkc1. However over-expression of the other Rho1 downstream 
effectors, Bni1, Fks1 or Skn7, are not able to suppress the tor2ts. These data, 
and the fact that growth on sorbitol suppresses the tor2ts, indicate that the lethal 
defects of the tor2ts strain are lack of actin organization and cell lysis probably 
due to cell wall defects.  Given that PAS kinase activation can suppress the tor2ts 
it must be that PAS kinase signaling acts to repair one or both of these defects 
through the activation of Rho1. This could be accomplished by Rho1-dependent 
activation of Pkc1 and actin rearrangement, activation of Fks1 and cell wall 
synthesis, or both. It remains to be determined which Rho1 downstream effectors 
are regulated by PAS kinase activation and which are required for tor2ts 
suppression.   
Ssd1 is required for PAS kinase to suppress the tor2ts. The role of Ssd1 in 
this signaling pathway remains unclear.  Its physical interaction with Ugp1 in a 
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phosphorylation dependent manner, however, strongly suggests that its 
suppressing function is a component of the Ugp1/Rom2 complex.  Two possible 
roles for Ssd1 in this complex are: 1) to stabilize the phosphorylated form of 
Ugp1; or 2) to function as a scaffold for the Rom2-Ugp1 association. Ssd1 clearly 
does increase the phosphorylation of Ugp1, presumably through preventing 
dephosphorylation.  This effect, however, could be a secondary effect of binding 
with Ssd1 and Rom2.  The model of Ssd1 as a scaffold is particularly attractive, 
because it would bring together Ugp1, the recipient of the activating 
phosphorylation signal, and Rom2, which likely provides the Rho1 activation 
output. 
The RNA binding capacity of Ssd1 raises the intriguing possibility that the 
complex also contains RNA. The complex may function to regulate specific 
mRNA stability, localization or translation or, alternatively, RNA may play a 
structural or regulatory role within the complex.  Unlike the described role of Ssd1 
in translational repression (24), the function of Ssd1 in suppression of the tor2ts is 
totally unaffected by phosphorylation on the known eight N-terminal residues.  
These data indicate that the two roles of Ssd1 are separable and likely totally 
distinct activities. One is regulated by phosphorylation at the N-terminus and 
involves regulation of mRNA translation. The second involves complex formation 
with Ugp1 and Rom2, which is independent of N-terminal phosphorylation. This 
duality may enable coordination between the cell wall synthesis/actin polarization 
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required for cell division and the spatially regulated expression of cell wall 
degrading enzymes that are needed for cell separation. 
The primary mechanism by which PAS kinase regulates this complex 
appears to be phosphorylation of Ugp1. Therefore, the phosphorylation of Ugp1 
plays at least two cellular roles. First, it causes the preferential partitioning of 
UDP-glucose toward cell wall biosynthesis at the expense of glycogen storage 
(21).  This function is independent of Ssd1. This effect is probably due to a 
phosphorylation-dependent conformational change, which promotes localization 
of the protein to the cell periphery. Second, Ugp1 phosphorylation nucleates the 
formation of a signaling complex that includes Ssd1 and Rom2. While these two 
effects are separable due to differential Ssd1 dependence, they may be related 
indirectly.  The PAS kinase-dependent translocation of Ugp1, which might be the 
mechanism of glucose partitioning, may also be required for the formation of the 
Ugp1-Ssd1-Rom2 complex. Peripheral localization would bring the complex into 
proximity with Rho1, which is known to localize to the cell periphery (43). The two 
functions of Ugp1 may both be dependent on translocation and may allow Ugp1 
to simultaneously produce UDP-glucose at the cell periphery and activate the 
Fks1 protein, which is responsible for the incorporation of UDP-glucose in cell 
wall biogenesis. This is the first evidence that Ugp1, thought only to catalyze the 
formation of UDP-glucose, has a distinct signaling function.  It remains to be 
determined, however, whether this signaling function is dependent upon the 
enzymatic activity of Ugp1 or Ugp1 simply plays a scaffolding role within the 
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complex. If enzymatic activity is required, it would be very interesting to 
determine the role of UDP-glucose in the complex.  This is a difficult question to 
answer given that the enzymatic activity of Ugp1 is required for cell viability and 
that Ugp1 forms a stable octamer (35). However future studies will ultimately 
shed light on the molecular basis of the signaling activity of this metabolic 
enzyme. 
The physiological significance of PAS kinase activation remains to be 
elucidated. One possibility is that PAS kinase is simply activated in response to 
various forms of stress, both structural and metabolic, and acts to stabilize the 
cell wall. This is accomplished by phosphorylation of Ugp1, which directly 
promotes cell wall production, and also activates Rho1, which leads to an 
increase in cell wall biogenesis via activation of Fks1. On the other hand, PAS 
kinase activation might function to enable growth under nonideal conditions.  
Rho1 activation leads to polarization of the actin cytoskeleton in coordination with 
cell growth and division. A progrowth role for PAS kinase is supported by the 
observation that an fks1Δ mutation suppresses the tor2ts(6). If PAS kinase were 
suppressing the tor2ts by simple upregulation of cell wall synthesis, deletion of 
FKS1 should exacerbate and not suppress the tor2ts phenotype. This proposed 
progrowth role is further supported by the fact that PAS kinase is a positive 
regulator of protein synthesis in yeast (19), which is clearly a progrowth function. 
In mammalian systems, PASK is activated in nutrient replete conditions to elicit 
the appropriate cellular response (18). Specifically, PASK kinase promotes 
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insulin synthesis in pancreatic β-cells, represses oxidative metabolism in skeletal 
muscle and upregulates lipid synthesis and storage in the liver.  These data 
support a role for PAS kinase in mediating nutrient-responsive anabolism, which 
has been conserved through evolution.  
Herein we detail a novel signaling network that connects PAS kinase and 
TOR signaling. There are many similarities between PAS kinase and TOR in S. 
cerevisiae and in mammals.  First, TOR has been clearly demonstrated to 
respond to nutrient replete conditions, both locally and globally, in order to elicit a 
progrowth response (6).  This function is analogous to the role for PAS kinase as 
described herein and elsewhere. Second, PAS kinase and TOR both have two 
closely related paralogs in S. cerevisiae (PSK1, PSK2 and TOR1, TOR2), but 
higher organisms only have one of each gene.  Third, mice lacking PAS kinase 
and mice lacking S6K1, a downstream target of Tor signaling, have a strikingly 
similar phenotype (18, 44). Specifically, they are both hypermetabolic, are 
resistant to diet-induced obesity and have ß-cell insufficiency. These similarities 
could be coincidental, but it is also possible that these two highly-conserved 
nutrient sensing kinases have a closer relationship. While we have shown that 
PAS kinase and TORC2 function in parallel pathways in S. cerevisiae to activate 
Rho1, their functions in higher organisms might be in more direct coordination. 
The cell autonomous decision to grow and divide must be responsive to 
environmental cues. In particular, it must integrate the nutritional environment to 
assure that sufficient energy sources and building blocks are available. Because 
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of the potential catastrophic consequences of mishandling this decision, cells 
have evolved multiple cellular energy sensors to detect the nutritional 
environment and signal appropriately. We have shown that PAS kinase functions 
in parallel to TORC2 to enable cell survival and growth under stress conditions.  
 
Methods 
Saccharomyces cerevisiae strain JRY626 (MATa Leu2 Ura3 Trp1 His4) 
was used as the JK9 parental strain and wild type strain. JRY421 (MATa/α His3 
Lys2 Met15 Ura3 Trp1 Leu2) was used as the W303 parental diploid, 
temperature sensitive strains were isolated via sporulation and dissection. 
Deletion mutant strains and strains expressing chromosomal-integrated FLAG-
tagged proteins were generated by standard PCR-based homologous 
recombination methods in diploids, followed by sporulation and tetrad dissection 
(Longtine et al., 1998). Yeast were transformed by the lithium acetate method, 
and grown at 30°C in SD medium (0.67% yeast nitrogen base, 2% glucose) with 
amino acids unless otherwise indicated. Complete strain and plasmid information 
is given in the Supporting Information for this Chapter.  
Glycogen assay was performed as previously described. Briefly, UGPase 
activity was determined by the rate of formation of glucose-1-phosphate from 
UDP-glucose in an NADP-linked glucose-6-phosphate dehydrogenase assay as 
previously described (35). The reaction mixture contained 50 mM Tris (pH 8.0), 
10 mM dithiothreitol, 10 mM MgCl2, 0.2 mM NADP, 10 mM glucose-1,6-
biphosphate, 2 mM UDP-glucose, 0.6 U phosphoglucomutase, 0.5 U glucose-6-
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phosphate dehydrogenase, 10 mM Na-pyrophosphate, and sample (whole-cell 
lysate). Assay was read at 340 nm in a 1 cm path cuvette in an Ultraspec 2000 
spectrophotometer (Amersham Pharmacia). Glycogen content was assayed as 
previously described (19). 
For Ugp1-Rom2 and Ugp1-Ssd1 co-immunoprecipitation experiments, the 
indicated strains were grown to log phase, harvested, resuspended and lysed in 
600 ul of IP buffer (25 mM KOAc, 25 mM HEPES pH 7.4, 0.2 mM EDTA, 0.2 mM 
EGTA, 10% glycerol, 0.02% NP-40, protease inhibitor cocktail (Sigma), 
PhoSTOP (Roche)). Cleared cell lysates were incubated with either anti-FLAG or 
anti-HA conjugated (Sigma) beads for 2 hours at 4 C.  The mixture was then 
rinsed 2 times in IP buffer. The beads were then resuspended in IP buffer and 
transferred into a spin column (Sigma). The beads were then rinsed 3 times in 
wash buffer (50 mM KOAc, 25 mM HEPES pH 7.4, 0.2 mM EDTA, 0.2 mM 
EGTA, 10% glycerol, 0.02% NP-40, protease inhibitor cocktail, PhoSTOP). The 
beads are then incubated with FLAG or HA peptide for 1 hour at room 
temperature and the elution is mixed with Laemelliʼs loading buffer.  The samples 
were then analyzed by western blot. 
Active Rho1 was assayed as previously described with modification (40, 
41). Rho1-HA expressing cells were grown to log phase, harvested and lysed in 
IP buffer (25 mM HEPES-KOH pH 7.9, 100 mM KOAc, 0.2 mM EDTA, 0.2 mM 
EGTA, 0.1% NP-40, 10% glycerol, protease inhibitor cocktail (Sigma), phoSTOP 
(Roche)). Cleared cell lysates were normalized using the Bradford assay. 
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Normalized cell lysates were incubated with GST-tagged RBD preconjugated to 
beads (cytoskeleton) for 2 hour at 4° C. Pelleted beads were washed three times 
with IP buffer. Protein bound to the beads was eluted using 1X Laemilliʼs buffer 
and subjected to 12% SDS-PAGE. Rho1 was detected using HA monoclonal 
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IStrain Background Genotype mating type 
JRY625 JK9 wildtype diploid 
JRY626 JK9 wildtype a haploid 
JRY627 Jk9 tor2::ADE2-3 tor2-21::YCplac111 a haploid 
JRY932 JK9 pskl::KanMX4 diploid 
JRY933 JK9 pSk2:: HphMX4 diploid 
JRY940 JK9 tor2:: ADE2-3 tor2-21 ::YCplac111 pskZ :KanMX4 diploid 
JRY950 JK9 tor2::ADE2-3 tor2-21::YCplac111 UGP1-SllA:TRPI a haploid 
JRY951 JK9 tor2::ADE2-3 tor2-21::YCplac111 psk2: :KanMX4 a haploid 
JRY952 JK9 psk2:: Kan MX 4 a haploid 
JRY953 JK9 UGP1-SllA:TAPI a haploid 
JRY1115 JK9 tor2:: ADE2-3 YCplac111: :tor2-21 rom2:: HphMX4 ssdl :: KanMX4 UGP1SllA:TRPI a haploid 
JRY1119 JK9 tor2 ::ADE2-3 tor2-21 ::YCplac111 ssd1 :: KanMX4 a haploid 
JRY1123 JK9 ssdl::KanMX4 a haploid 
JRY1118 JK9 tor2::ADE2-3 tor2-21::YCplac111 romZ:HphMX4 a haploid 
JRY1122 JK9 rom2:: HphMX4 a haploid 
JRY649 W303 tor2:: HphMX tor2-21 :YCplac111 a haploid 
JRY652 W303 tor2-21:YCplac111 a haploid 
JRY1735 JK9 tor2::ADE2-3fTOR2 tor2-21::YCplac111 ROM2IROM2-FLAG:KanMX4 psk2::NatMXIPSK2 diploid 
JRY1736 JK9 tor2: :ADE2-3 tor2-21 : :YCplac111 ROM2-F LAG: Kan MX4 a haploid 
JRY1740 JK9 tor2:: ADE2-3 tor2-21 ::YCplac111 ROM2-FLAG:KanMX4 UGP1-SllA: TAPI a haploid 
JRY1741 JK9 tor2::ADE2-3 tor2-21::YCplac111 ROM2-FLAG:KanMX4 UGP1-SllA:TRPI diploid 
JRY1737 JK9 tor2::ADE2-3 tor2-21::YCplac111 a haploid 
JRY1739 JK9 tor2:: ADE2-3 tor2-21 ::YCplac111 Ugpl-SllA: TAPI a haploid 
Iplasmid gene Yeast origin selection 
pRS426 empty vector 2u URA3 
pJR273 empty vector 2u MET25 
PJR1413A PSKI 2u URA3 
pJR1413C PSK2 2u URA3 
pJR1413D PSK2-KD(K870R) 2u URA3 
pJR6115B SSDlv cen MET25 
pJR6115A SSDlv none MET25 
pJR1058B PGM2 2u URA3 
pJR11159 SSD1-HA cen URA3 
pJR9889A Rhol-HA cen URA3 
pJR5282 tor2-21 cen LEU2 










Figure 2-S1). 1 M sorbitol can suppress the tor2ts. Indicated strains were grown to 
stationary phase YPAD. Serial dilutions of each strain were then plated onto synthetic 
dextrose plates supplemented with 1 M sorbitol. The plates were then incubated at 
















Figure 2-S2). Ssd1-8A, but not Ssd1-8D or Ssd1-8E, over-expression is lethal in 
the Jk9 strain. Ssd1-8A/8D/8E were over-expressed by a galactose inducible 
promoter. Strains were grown to stationary phase and serially diluted in water. The 
strains were then grown at 25˚ C for 3 days on synthetic galactose media. 
 




















Figure 2-S3). Neither ROM1 nor TUS1 is required for PAS kinase to suppress the 
tor2ts. Strains were grown to stationary phase and serially diluted in water. The strains 

















Figure 2-S4). Stability of Rom2 and Ssd1, but not Ugp1, decrease with extended 
heat shock. A strain containing Ssd1-HA and Rom2-FLAG was incubated at 37˚ C for 
the indicated time. Crude cell lysates were then prepared and subjected to western 
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The metabolic syndrome, a complex set of phenotypes typically
associated with obesity and diabetes, is an increasing threat to
global public health. Fundamentally, the metabolic syndrome is
caused by a failure to properly sense and respond to cellular
metabolic cues.We studied the role of the cellularmetabolic sensor
PAS kinase (PASK) in the pathogenesis of metabolic disease by
using PASK!/! mice. We identified tissue-specific metabolic phe-
notypes caused by PASK deletion consistent with its role as a
metabolic sensor. Specifically, PASK!/! mice exhibited impaired
glucose-stimulated insulin secretion in pancreatic "-cells, altered
triglyceride storage in liver, and increased metabolic rate in skel-
etal muscle. Further, PASK deletion caused nearly complete pro-
tection from the deleterious effects of a high-fat diet including
obesity and insulin resistance. We also demonstrate that these
cellular effects, increased rate of oxidative metabolism and ATP
production, occur in cultured cells. We therefore hypothesize that
PASK acts in a cell-autonomousmanner tomaintain cellular energy
homeostasis and is a potential therapeutic target for metabolic
disease.
metabolism ! PAS domain ! nutrient sensing ! obesity
Because of changes in diet and lifestyle, the incidence of obesityand type 2 diabetes is increasing dramatically worldwide. Type
2 diabetes arises when pancreatic !-cells fail to secrete sufficient
insulin to compensate for peripheral insulin resistance, a condition
severely aggravated by obesity (1, 2). Type 2 diabetes is now widely
viewed as a manifestation of a broader underlying metabolic
disorder called the metabolic syndrome, which is characterized by
hyperglycemia, hyperinsulinemia, dyslipidemia, hypertension, vis-
ceral obesity, and cardiovascular disease (3). The World Health
Organization estimates that the current decade will witness a 46%
increase in diabetes incidence worldwide (from 151 million to 221
million), with the vast majority of this increase being due to
metabolic syndrome-related type 2 diabetes (4).
Cellular energy andnutrient sensors determinehowcells respond
to excessive nutrients, and aberrant nutrient and energy sensing is
a contributing factor to metabolic syndrome development (5, 6).
AMP-activated protein kinase (AMPK) and mammalian target of
rapamycin (mTOR) are two well studied and evolutionarily con-
served cellular energy and nutrient sensors. AMPK is activated in
response to intracellular ATP depletion and acts to switch the
cellular metabolic program from ATP consumption to ATP pro-
duction (7). In contrast to AMPK, mTOR is activated by sufficient
cellular energy or nutrients, particularly amino acids (8). Activation
of mTOR stimulates cell growth by increasing protein synthesis
through phosphorylation of ribosomal S6 kinase (S6K) and eIF4E-
binding protein (9).DecreasedAMPKactivity and elevatedmTOR
activity have been linkedwith obesity, diabetes, and cancer (10–12).
Like AMPK and mTOR, PAS kinase (PASK) is a nutrient-
responsive protein kinase conserved from yeast to humans. The
PAS domain of PASK specifically interacts with the kinase catalytic
domain and inactivates the kinase in cis (13). Based on biochemical
and genetic data, a model has been proposed wherein a small
metabolite activates PASK by directly interacting with the PAS
domain and disrupting its interaction with the kinase domain (5, 14,
15). Studies in cultured pancreatic !-cells support a role for PASK
in nutrient sensing and response. Specifically, PASK has been
shown to be regulated by glucose both posttranslationally and at the
level of gene expression, and PASK activity is required for glucose-
stimulated insulin expression in Min-6 cells (16).
We sought to address the in vivo role of PASK in pancreatic!-cell
function and energy homeostasis. Using PASK!/! mice (17), we
demonstrate that PASK is required for normal !-cell insulin
secretion. We also demonstrate that PASK deletion results in
resistance to the phenotypes caused by a high-fat diet, including
obesity, insulin resistance, and hepatic triglyceride accumulation.
This protection is likely due to increased metabolic rate and energy
expenditure in PASK!/! mice independent of the activity of
AMPK, mTOR, and peroxisome proliferator-activated receptor "
coactivator 1 (PGC-1). Increased oxidative metabolism and ATP
generation are also observed in cultured cells upon acute PASK
knockdown by RNAi. These cellular effects, which recapitulate
effects observed in vivo, support the hypothesis that PASK func-
tions as a cell-autonomous regulator of cellular energy balance (14).
Results
Impaired Glucose-Stimulated Insulin Secretion (GSIS) in PASK!/!Mice.
Previously, PASK was shown to be required for the induction of
preproinsulin promoter activity by high glucose concentrations in
culturedMin-6 !-cells (16). To examineGSIS in PASK!/!mice, we
measured plasma insulin levels before and after an intraperitoneal
glucose injection. As shown in Fig. 1A, insulin levels in PASK!/!
mice are modestly but significantly lower than those in WT litter-
mates at both 5 min and 45 min after glucose injection. This defect
in insulin secretion is also manifest in isolated islets of Langerhans
in vitro. Using islet perifusion experiments, we foundPASK!/! islets
to be defective in GSIS, particularly at higher glucose concentra-
tions (Fig. 1B), but normal in depolarization-induced insulin se-
cretion (data not shown). The total insulin secreted by PASK!/!
islets in these experiments was 56% the total secreted byWT islets.
Defects in insulin secretion are often accompanied by alterations
in islet morphology or !-cell mass. To determine whether these
Author contributions: E.D.A., D.A.M., and J.R. designed research; H.-X.H., C.M.C., W.S.,
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parameters are affected in PASK!/! mice, we examined islet
organization and morphology by glucagon and insulin double
immunostaining. No defect in islet morphology, size, or !-cell area
was observed in PASK!/! mice (Fig. 1C and data not shown). We
also observed no significant difference between WT and PASK!/!
mice in Ins-1 or Ins-2 mRNA levels (see supporting information
(SI) Fig. 6A) or in total pancreatic insulin (SI Fig. 6B). The
expression levels of several genes involved in insulin transcription
and GSIS, including Pdx-1, MafA, GLUT2, and glucokinase, were
also unchanged in PASK!/! islets (data not shown). We therefore
suggest that the GSIS defect observed in PASK!/! mice is likely a
result of impaired !-cell glucose sensing.
Improved Glucose Tolerance, Increased Insulin Sensitivity, and Resis-
tance to Obesity in High-Fat Diet (HFD)-Fed PASK!/! Mice. To assess
whether PASK is required for the maintenance of glucose ho-
meostasis, we performed a glucose tolerance test (GTT), in which
plasma glucose levels were monitored over time after glucose
injection. PASK!/! mice displayed a slight and statistically insig-
nificant glucose intolerance (Fig. 2A). Insulin sensitivity, as mea-
sured by insulin tolerance test (ITT), was identical in WT and
PASK!/!mice (Fig. 2B).When fed aHFD,C57BL/6Jmice develop
obesity and a set of symptoms reminiscent of the metabolic
syndrome, including insulin resistance (18). To examine glucose
homeostasis under this stress condition, we performed GTT and
ITT experiments on HFD-fed WT and PASK!/! mice. Whereas
HFD-fed WT mice developed glucose intolerance and insulin
resistance, PASK!/! mice were completely protected from these
effects (Fig. 2C andD; compare with Fig. 2 A and B). As expected,
fasting insulin levels of HFD-fed PASK!/! mice were substantially
lower than the fasting insulin levels of WT mice (SI Fig. 7A).
PASK!/! mice were also protected from HFD-induced obesity.
WT and PASK!/!mice were of similar weight on normal chow diet
(NCD) (Fig. 2E), but theweight gain ofPASK!/!mice onHFDwas
significantly less than that of WT littermates (Fig. 2F). After 8
weeks of HFD feeding, the body weight of PASK!/! mice was
similar to NCD-fed WT or PASK!/! mice. Analysis of body
composition by dual-energy x-ray absorptiometry showed that the
difference in total body weight between WT and PASK!/! HFD-
fed mice is completely accounted for by decreased fat mass in
PASK!/! mice (SI Fig. 7B).
PASK!/! Mice Exhibit Increased Whole-Body Energy Expenditure and
Increased Metabolic Rate in Skeletal Muscle. We hypothesized that
the PASK!/! lean phenotype is responsible for the improved
glucose tolerance and insulin sensitivity; therefore, we sought to
understand the basis for this phenotype. Obesity is the result of an
imbalance between energy intake (in the form of feeding) and
energy expenditure (in the form of physical activity and basal
metabolism) (19). We therefore measured O2 consumption, CO2
production, food intake, and locomotor activity by using metabolic
chambers. Food intake and locomotor activity were similar, but
PASK!/! mice consumed more O2, produced more CO2, and
generatedmore heat thanWT littermates (Fig. 3A).Relative toWT
mice,HFD-fedPASK!/!mice have a slight substrate preference for
carbohydrate over fat, as indicated by the respiratory quotient
(0.91" 0.02 for WT mice and 0.93" 0.02 for PASK!/! mice, P#
0.05, night values). This hypermetabolic phenotype in PASK!/!
mice was also manifest in permeabilized soleus muscle fibers,
wherein we observed elevated ATP production from succinate in
PASK!/! muscle (Fig. 3B).
One potential explanation for the observed increase in oxidative
metabolism was an increase in mitochondrial mass in PASK!/!























































Fig. 1. Impaired insulin secretion but normal islet morphology in PASK!/!
mice. (A) Plasma insulin concentrations before and after i.p. glucose injection
intoWT (black bars) and PASK!/! (gray bars) (n$ 24male mice per genotype,
12weeksof age). (B) Perifusionof 15–17 isolated isletswith a3–30mMglucose
ramp in gassed Krebs buffer for 40 min (n$ 4 female mice, 16 weeks of age).
Area under the curve: 1,146 " 129 for WT islets and 646 " 171 for PASK!/!
islets (P # 0.05). The experiment was performed twice with similar results. *,
P # 0.05. Data shown represent the mean " SD. (C) Immunostaining of
pancreatic sections by using anti-insulin (red) and anti-glucagon (green) an-



















































































































































Fig. 2. PASK!/!micewere protected fromdiet-induced glucose intolerance,
insulin resistance, and obesity. (A–D) GTT and ITT with WT and PASK!/!mice
fed with either NCD (A and B) or HFD (C and D). Plasma glucose levels were
determinedbefore andat indicated times after i.p. glucose (A andC) or insulin
(B and D) injection. (E and F) Growth curves of WT and PASK!/!mice on NCD
(E) orHFD (F) beginningat 12weeksof age.All data represent themean" SEM
for 12 male mice of each genotype. *, P # 0.05; **, P # 0.01.
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subsequent quantification of both mitochondrial number and area
showed no difference between PASK!/! and WT soleus muscle
(Fig. 3D and data not shown). Further, the activity of citrate
synthase, a marker of mitochondrial density (20), was identical in
PASK!/! and WT soleus muscle extracts (Fig. 3E). We also
observed no difference in the mRNA levels of either PGC-1! or
PGC-1" (Table 1), important transcriptional regulators of mito-
chondrial biogenesis (21, 22). We conclude that PASK deficiency
leads to increased mitochondrial metabolism and ATP production
that is independent of increased mitochondrial biogenesis.
PASK!/!Mice Exhibit Reduced Liver Triglyceride Accumulation.Diet-
induced obesity is typically accompanied by increased lipid accu-
mulation in peripheral tissues, which is strongly associated with the
development of insulin resistance (23, 24). We examined liver lipid
content both by histological oil red O staining (Fig. 4A) and by
enzymatic triglyceride quantification (Fig. 4B). In both cases,
HFD-fed PASK!/! mice were completely protected from the
increased lipid accumulation observed in HFD-fed WT mice.
Increased AMPK activity and reduced mTOR pathway activity
cause resistance to diet-induced obesity, as demonstrated by using
transgenic and pharmacologic strategies (25, 26). Given their joint
role as nutrient sensors, we sought to determine whether PASK
deletion affected AMPK or mTOR activity. We performed West-
ern blots of WT and PASK!/! liver samples from NCD- and
HFD-fed mice by using antibodies recognizing phospho-AMPK
(Thr-172) and phospho-S6K (Thr-389), which are widely accepted
as markers of AMPK and mTOR activity, respectively. As shown
in Fig. 4C, we observed no difference between WT and PASK!/!
liver under either NCD or HFD conditions. We also observed no
change in phospho-AMPK and phospho-S6K in gastrocnemius
muscle (data not shown), suggesting the function of PASK is




























































































Fig. 3. PASK!/! mice exhibit increased metabolic rate without increased
mitochondrial mass. (A) Metabolic chamber analysis of WT and PASK!/!mice
(n" 3malemice, 24weeks of age). VO2, O2 consumption; VCO2, CO2 emission.
Laser beam breaks are a measure of locomotor activity. For each parameter,
the average of the WT value was set at 100%. The data presented are
nighttime values (6 p.m. to 6 a.m.). Daytime values exhibited a similar differ-
ence between WT and PASK!/! mice. (B) Maximal ATP production rate in
saponin-permeabilized soleus muscle fibers, measured in the presence of 1
mM exogenous ADP and succinate (n " 10 male mice, 16 weeks of age). (C)
Representative electron micrographs of soleus muscle from 16-week-old WT
and PASK!/! male mice. (Original magnification: #8000.) Four sections from
each animal and three animals per genotype were examined. (D) Quantifica-
tion of mitochondrial number manually counted from 10 electron micro-
graphs per genotype. The data presented are the mean $ SD and are nor-
malized to Z line number. (E) Citrate synthase activity in soleusmuscle extracts
from WT and PASK!/! mice (n " 6 male mice, 16 weeks of age). The data
presented are the mean $ SD.
Table 1. Normalized transcript levels in HFD-fed PASK!/! liver






Glut2 0.92 0.17 0.37
G6Pase 0.66 0.34 0.16
PEPCK 0.88 0.23 0.38
PGC-1! 0.88 0.17 0.24
PGC-1" 1.00 0.14 1.00
PPAR! 0.90 0.12 0.17
LXR! 1.02 0.13 0.82
SREBP-1c 0.75 0.26 0.32
FAS 0.74 0.30 0.53
ACL 0.93 0.52 0.85
MCAD 0.79 0.42 0.46
LCAD 1.00 0.14 1.00



























































Fig. 4. Reduced triglyceride accumulation in PASK!/! livers on HFD. (A)
Representative oil red O staining of liver cryosections from 24-week-old WT
and PASK!/!malemice onNCDandHFD after an 8-h fast. (B) Liver triglyceride
(triacyl glycerol, TAG) content in 24-week-old WT and PASK!/! mice on NCD
and HFD harvested after an 8-h fast (n " 3–5 male mice). (C) Immunoblot
analysis of phospho-AMPK (Thr-172), phospho-S6K (Thr-389), and tubulin (as
loading control) levels in liver extracts fromWTand PASK!/!mice onNCD and
HFD. Results from twomiceper groupare shown. Total AMPKand S6Kprotein
levels were also analyzed and found to be identical among the groups. (D)
SCD1, fatty acid elongase (FAE), CD36, PPAR#, CYP3A11, and PXRmRNA levels
in liver fromWT and PASK!/!mice on HFDmeasured by quantitative RT-PCR.
The data shown are the average of n " 6 per group with the WT value set as
1. RPL13A was used as the normalizer. All data presented are the mean$ SD.
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We also determined the levels of transcripts related to lipid
metabolism in liver from HFD-fed WT and PASK!/!mice. Levels
of stearoyl-CoA desaturase 1 (SCD1) (27), long-chain fatty acid
elongase (28), fatty acid transporter (CD36) (29), and the lipid-
responsive nuclear hormone receptor peroxisome proliferator-
activated receptor ! (PPAR!) (30) are all significantly decreased in
PASK!/! liver (Fig. 4D). Lower expression of each of these genes
is consistent with decreased hepatic lipid synthesis and triglyceride
accumulation. The transcripts of other genes involved in fatty acid
metabolism, including FAS, ACC-1, and SREBP-1c, showed no
difference between WT and PASK!/! liver (Table 1).
The altered lipid accumulation and the pattern of gene expres-
sion observed in PASK!/! liver is strikingly similar, albeit opposite,
to that observed in a transgenic mouse expressing a constitutively
active pregnane X receptor (PXR) in liver (31). This observation
raised the possibility that the PASK-dependent effects on lipid
metabolism in liver might be mediated through a decrease in PXR
expression or function. Indeed, we observed a decrease in the
mRNA levels of a well established PXR target gene CYP3A11 (32)
in PASK!/! liver. The expression of the PXR gene itself is not
altered by PASK deletion (Fig. 4D); therefore, if PASK does
regulate PXRactivity, it does so via amechanismdistinct from gene
expression.
Acute PASK Silencing Increases Oxidative Metabolism in Cultured
Cells. To address the possibility that the observed hypermetabolic
phenotype in skeletal muscle is a secondary or adaptive response to
PASK deletion inmice, we generated two independent L6myoblast
cell lines wherein we could acutely silence PASK expression by
using short hairpin RNA (shRNA) upon doxycycline removal. As
shown in Fig. 5A, these two clones both exhibit an "50% decrease
in PASK mRNA upon doxycycline removal compared with the
scrambled shRNA control. On PASK knockdown, we observed a
large increase in both glucose and palmitate oxidation (Fig. 5B and
C). This increased substrate metabolism is accompanied by ele-
vated steady-state levels of ATP, presumably a result of increased
mitochondrial ATP production (Fig. 5D). We also generated
L6-derived cells with constitutive knockdown of PASK and ob-
served increased glucose oxidation and ATP levels (data not
shown). These data in cultured cells indicate that loss of PASK leads
to an acute and cell-autonomous increase in mitochondrial metab-
olism and ATP production.
Discussion
Herein we describe a physiological role for PASK in regulating
mammalian energy balance. PASK!/! mice are protected from
HFD-induced obesity and from other metabolic perturbations that
accompany HFD-induced obesity. Levels of insulin sensitivity and
glucose tolerance inHFD-fed PASK!/!mice are nearly identical to
the levels in NCD-fed WT or PASK!/! mice. These changes in
organismal energy and glucose homeostasis are likely manifesta-
tions of an underlying alteration in metabolic regulation in indi-
vidual cells and tissues. We have previously described a role for
PASK in glucose-responsive processes in pancreatic "-cells (16).
We show here that PASK!/! mice exhibit hypoinsulinemia in vivo
and PASK!/! islets have impaired GSIS in vitro. These effects are
not due to decreased insulin gene expression or altered islet
morphology or mass, but likely to impaired "-cell glucose sensing.
Another group did not observe this decrease in GSIS in PASK!/!
mice (33).
We observed a striking protection from HFD-induced hepatic
steatosis in PASK!/! mice. This is accompanied by a significant
decrease in the transcript levels of SCD1, fatty acid elongase, CD36,
and PPAR!. SCD1 is the rate-limiting enzyme in the synthesis of
monounsaturated fatty acids, which are the major substrates for
triglyceride synthesis (34). SCD1!/!mutant mice exhibit decreased
liver triglyceride accumulation and fatty acid biosynthesis and are
protected from HFD-induced obesity (35, 36). Fatty acid elongase
is required for de novo fatty acid synthesis (37). CD36 (also known
as fatty acid translocase) is a putative fatty acid transporter.
Interestingly, CD36 is a target gene of PPAR! (38); thus, the
decreased expression of CD36 could be secondary to the lower
expression of PPAR! inPASK!/! liver.PPAR! expression has been
shown to positively correlate with obesity inmultiplemousemodels
(39). Decreased expression of each of these genes in liver is
consistent with decreased lipid content observed in HFD-fed
PASK!/! mice. These alterations in gene expression, and particu-
larly a decrease in CYP3A11 expression, are consistent with de-
creased PXR activity in PASK!/! liver (31). The expression of PXR
is not different, however, suggesting that PASK might regulate
PXR via direct phosphorylation, through altered abundance of a
PXRagonist, or through othermechanisms.Alternatively, the PXR
paralog CAR, which activates an overlapping set of genes, might be
down-regulated upon PASK deletion. These hypotheses await fur-
ther investigation.
Deletion of PASK leads to organismal hypermetabolism as
measured by O2 consumption, CO2 production, and heat genera-
tion. This hypermetabolism is also exhibited in isolated permeabil-
ized skeletal muscle, wherein we observed increased ATP produc-
tion. A number of mouse models exhibit similar hypermetabolism.
Three aspects of thePASK!/! phenotypemake it unusual. First, the
elevated metabolic rate is not caused by impaired metabolic effi-
ciency and concomitantly increased substrate demand. In fact, we
observed increased ATP production both in isolated PASK!/!
skeletal muscle and in cultured cells upon acute PASK knockdown.
Further, energy stress is not apparent, as there is no AMPK
hyperactivation in liver or skeletal muscle from PASK!/! mice as
measured by phosphorylation of either AMPK or ACC (Fig. 4C
anddata not shown). Second, the increasedmitochondrial oxidative
metabolism occurs without changes in mitochondrial mass or
number or in PGC-1#or -" expression. Third, this phenotype seems
to be a property of individual cells because it is recapitulated in L6
myoblasts upon acute PASK knockdown. Although the detailed
mechanism for increased oxidative metabolism upon PASK loss is
unclear, it is almost certainly due to changes in mitochondria. First,
the ex vivo soleus ATP measurements were performed under







































































































Fig. 5. Increased oxidative metabolism and cellular ATP content upon PASK
silencing in L6 cells. (A) PASK mRNA levels in L6 clones expressing either
scrambled or PASK shRNA in the absence of doxycycline. Data represent the
mean # SD of triplicates per group. (B) Measurement of 14CO2 released from
indicated L6 clones incubated in [14C]glucose (n $ 3). (C) Measurement of
14CO2 released from indicatedL6 clones incubated in [14C]palmitate (n$3). (D)
Cellular ATP content measurement normalized to protein in extract.
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the observation that both glucose and palmitate oxidation were
increased upon PASK knockdown suggests that the alteration lies
downstream of where these two metabolic pathways converge,
namely at the level of the mitochondrial tricarboxylic acid cycle.
We have previously proposed that PASK functions as a cell-
autonomous nutrient sensor (5, 14). PASK is posttranslationally
activated by elevated glucose medium in cultured !-cells (16),
probably through allosteric control via its regulatory PAS domain
(13, 15). PASK also is regulated by nutrient status at the level of
gene expression (16). Taking these observations together, we
conclude that PASK integrates multiple cues to monitor cellular
energetic status. As inferred from the loss-of-function phenotype,
the effect of PASK activation seems to be cell type specific and part
of an appropriate nutrient response for each cell type analyzed.
PASK activation in !-cells contributes to insulin secretion. PASK
activation in hepatocytes increases the synthesis and accumulation
of storage lipids such as triglycerides. PASK activation in skeletal
muscle results in decreased ATP generation both from carbohy-
drate and fatty acid oxidation. We, therefore, propose a model
wherein PASK acts as a sensor, integrator, and transducer of a
metabolic sufficiency signal. The transduction pathway downstream
of PASK is cell type specific but, at least in skeletal muscle,
decreases mitochondrial oxidative metabolism and ATP produc-
tion.When PASK is artificially lost, this metabolic sufficiency signal
is not transduced and the result is chronically elevated mitochon-
drial metabolism, resulting in protection from ectopic HFD-
induced lipid accumulation. As with the other well known meta-
bolic sensory kinases AMPK and mTOR, we propose that PASK
may be an important regulator of human metabolic disease.
Methods
Animals. PASK!/! mice were genotyped as described (17). After
the fifth backcross into C57BL/6 (Charles River Laboratories,
Wilmington, MA), 12- to 24-week-old males were used for all
experiments except that the islet perifusion studies were performed
on females.Miceweremaintained on aNCD (3080;HarlanTeklad,
Madison, WI) or a HFD from 12 weeks of age (45% fat by calories,
D12451; ResearchDiets, NewBrunswick, NJ). In each experiment,
age-matched WT littermates were used as controls for PASK!/!
mice. All procedures were approved by the institutional animal care
and use committee of University of Utah.
Cell Culture. Rat L6 myoblasts were provided by Scott Summers
(University of Utah, Salt Lake City, UT). Cells were maintained at
37°C under 5% CO2 in DMEM supplemented with 10% FBS
(HyClone, Logan, UT), 0.1 mg/ml penicillin and 0.1 mg/ml strep-
tomycin (Life Technologies, Grand Island, NY).
GTT/ITT and Serum Insulin Measurement. For GTT and plasma
insulin measurement, experimental animals were fasted for 6 h,
after which glucose (1 g/kg body weight) was injected i.p. At the
indicated times, tail vein blood was sampled for glucose determi-
nation with a glucometer (Bayer, Pittsburgh, PA) or for insulin
measurement by using the Sensitive Rat Insulin RIA kit (Linco
Research, St. Charles, MO). For ITT, human recombinant insulin
(0.75 unit/kg of body weight; Novo-Nordisk, Copenhagen, Den-
mark) was injected i.p. to randomly fed mice and blood glucose
levels were determined at the indicated times.
Islet Isolation and Perifusion. Islets of Langerhans were isolated
from pancreas by using the intraductal liberase (Roche Applied
Science, Indianapolis, IN) digestion method as described in ref. 40.
Fifteen to 17 size-matched islets were individually handpicked and
used for perifusion experiments as described (40). The glucose and
released insulin in fractions of perifusion buffer were measured by
using a Glucose Analyzer (Beckman Instruments, Fullerton, CA)
and Sensitive Rat Insulin RIA kit (Linco Research), respectively.
Metabolic Chamber Studies. Indirect calorimetry was performed
with a four-chamber Oxymax system (Columbus Instruments,
Columbus, OH). Animals were allowed to adapt to the metabolic
chamber for 4 h and then VO2, VCO2, heat production, food and
water intake, andmovement weremeasured every 15min for 3 days
from individually housedmice. Averaged data from 6 p.m. to 6 a.m.
are expressed as night values and data from 6 a.m. to 6 p.m. are
expressed as day values.
Mitochondrial Respiration Experiment. Soleus fibers were separated
and then permeabilized by saponin. Maximal (ADP-stimulated)
ATP production rate was determined by exposing fibers to 1 mM
exogenous ADP and succinate as described (21).
Citrate Synthase Activity Assay. Citrate synthase activity was mea-
sured by the spectrophotometric method as described (41). In brief,
frozen soleus muscle was homogenized on ice and citrate synthase
was released from mitochondria by freezing and thawing the
homogenate. The reaction was initiated by addition of oxaloacetate
into 1 ml of diluted homogenate in reaction buffer containing
acetyl-CoA, and then monitored at 412 nm for 3 min with an
Ultrospec 3000 spectrophotometer (Amersham, Piscataway, NJ).
Histological Analysis. For immunostaining, dissected pancreata
were fixed overnight at room temperature in 10% formalin, par-
affin-embedded, andmicrotome-sectioned at 5"m thickness. After
deparaffinization and rehydration, the sections were sequentially
treated with 3%H2O2, target retrieval solution (DAKO, Glostrup,
Denmark), and blocking solution. The sections were then incubated
with antiglucagon (Vector Laboratories, Burlingame, CA), fol-
lowed by secondary antibody labeled with AlexaFluor 488 (Mo-
lecular Probes, Carlsbad, CA), and anti-insulin (DAKO), followed
by AlexaFluor 594-labeled secondary antibody. Fluorescent con-
focal images were captured, overlaid, and analyzed by National
Institutes of Health (NIH) ImageJ software. For electron micros-
copy analysis, soleus muscle was fixed in EM fixative, dehydrated in
graded ethanol, and embedded in Poly Bed plastic resins for
sectioning as described (21). Soleus mitochondrial number was
quantified in blinded fashion from electron micrographs at the
magnification of "8000 and normalized to Z line number. For oil
red O staining, frozen liver samples were embedded in OTC
reagent (Tissue-Tek; Sakura Finetek, Hatfield, PA) and sectioned
at 8 "m in cryostat. Cryosections were fixed in formaldehyde vapor
at 50°C, incubated in 0.5% oil red O in isopropyl alcohol, and
counterstained with hematoxylin (Sigma, St. Louis, MO). After
rinsing in distilled water, liver sections were mounted with perma-
nent aqueous mounting medium Gel/Mount (Biomeda, Foster
City, CA) and photographed by using light microscopy at "40
magnification. All images were acquired at the University of Utah
Imaging Core Facility.
Liver Triglyceride Content Measurement. Quantitative analysis of
liver triglyceride content was performed by saponification of liver
in ethanolic KOH as described (42). After neutralization with
MgCl2, glycerol produced during hydrolysis was measured by a
colorimetric assay with Free Glycerol Reagent and Glycerol Stan-
dard Solution (Sigma).
Western Blotting. Liver lysates were prepared by homogenizing
50–100mg snap-frozen liver slices in cell lysis buffer (Cell Signaling
Technology, Beverly, MA) by using a Tissue-Tearer rotor. After
centrifugation at 20,000" g for 30min at 4°C, the supernatantswere
collected and protein concentrations were determined by Ad-
vanced Protein Assay Reagent (Cytoskeleton, Denver, CO). About
50 "g of protein from each sample was separated by SDS/PAGE,
transferred to a PVDF membrane (Fisher, Waltham, MA), and
blotted with indicated antibodies according to the manufacturer’s
15470 ! www.pnas.org"cgi"doi"10.1073"pnas.0705407104 Hao et al.
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protocol. Phospho-AMPK (Thr-172), phospho-S6K (Thr-389), and
tubulin antibodies were purchased fromCell Signaling Technology.
Real-Time Quantitative RT-PCR. Total RNA was extracted from
tissues or cells by using RNAStat60 reagent (Tel-Test, Friends-
wood, TX) and purified with RNeasy Mini kit (Qiagen, Valencia,
CA), according to the manufacturer’s instructions. First-strand
cDNA synthesis was carried out with SuperScript III reverse
transcriptase (Invitrogen, Carlsbad, CA). Real-time PCR was per-
formed on a LightCycler (Roche Diagnostics, Indianapolis, IN) by
using the SYBR Green-based method as described (40). Melting
curve analysis and amock reverse transcribed control were included
to ensure the specificity of the amplicons. Primer sequences for
indicated transcripts are available on request.
Generation of Inducible PASK Knockdown Cells. pRevTet-Off-IN
retroviral vector was purchased from Clontech (Mountain View,
CA), and retrovirus was produced according to the manufacturer’s
instructions by using Fugene transfection reagent (Roche Applied
Science) and Phoenix-Ampho retroviral packaging cell line (Amer-
ican Type Culture Collection, Manassas, VA). L6 cells were in-
fected with the generated Tet-Off retrovirus in the presence of 6
mg/ml Polybrene, and 48 h after infection G418 was added to the
medium at a final concentration of 200 !g/ml. After 2 weeks of
selection, G418-resistant colonies were individually harvested by
using cloning cylinders (Corning, Corning, NY) and screened for
inducibility with pRevTRE-Luc (Clontech) virus. shRNA oligonu-
cleotide duplexes containing sequences targeting rat PASK gene
and a scrambled shRNAwere designed by using Invitrogen web site
software and cloned into tetracycline-regulated retroviral SIN-
TREmiR30-PIG (TMP) vector (OPEN Biosystems, Huntsville,
AL). Retrovirus expressing the inducible hairpins was generated
and used to infect highly inducible Tet-Off L6 clones as verified by
luciferase assay. Finally, 2 !g/ml puromycin as well as 2 !g/ml
doxycycline was applied and puromycin-resistant clones were iso-
lated as described above. PASK knockdown clones were screened
by quantitative RT-PCR analysis of PASK mRNA levels in the
absence and presence of doxycycline. PASK targeting hairpin
sequence: GATGCCAAGACCACAGAGA and GCGCAGA-
CAAGCTCAAAGA. Scrambled sequence: GCGCAGA-
CAAGCTCAAAGA.
Glucose and Palmitate Oxidation Measurement. Glucose oxidation
rates were determined according to previously described methods
(43). In brief, triplicate samples of L6 cells were incubated with 500
!l of oxygenated Krebs–Ringer buffer containing 5 mM unlabeled
glucose, 2 !Ci of [U-14C]glucose (MP Biochemicals, Aurora, OH),
and 0.4% BSA (wt/vol) in a 24-well plate. A UniFilter-24 GF/B
plate (Packard Instruments, Waltham, MA) was sealed with an
adhesive sheet by using vacuum grease, and 200 !l of 10! hyamine
hydroxide (PerkinElmer Sciences, Waltham, MA) was pipetted
onto each filter for CO2 capture. Finally, the 24-well plate was
sealed with a rubber gasket. The apparatus was incubated with
gentle shaking for 2 h at 37°C and the experiment was stopped by
injecting 100 !l of 1 M perchloric acid per well. Filters were
removed, and captured 14CO2 was measured by scintillation count-
ing. Control incubations lacking cells were included in each plate.
For palmitate oxidation, the same procedure was used except using
Krebs–Ringer buffer containing 1 mM glucose, 0.5 mM unlabeled
palmitate, 1!Ci of [1-14C]palmitate (MPBiochemicals), and 1mM
carnitine.
Cellular ATP Content Measurement. L6 cells were washed with PBS,
harvested by trypsinization, and pelleted by centrifugation. The
cells were then lysed in 1 M perchloric acid on ice to precipitate
cellular proteins. After centrifugation at 20,000! g for 10 min, the
supernatant was transferred into a new tube and neutralized with
an equal volume of 1 M KOH. The ATP content was measured by
an ATP Determination kit (Invitrogen) according to the manufac-
turer’s instructions.
Statistical Analysis. Data are presented as mean " standard devi-
ation unless otherwise indicated. A two-tailed equal variance t test
was used to compare differences, and the null hypothesis was
rejected at the 0.05 level.
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Figure 3-S6). Analysis of insulin mRNA and protein levels. (A) 
Quantitative RT-PCR analysis of insulin transcript levels in WT and 
PASK-/- islets from 16-week-old male mice. Data represent the 
mean ± SD of six mice per genotype. RPL13A was used as 
normalizer. (B) Measurement of total insulin extracted from whole 
pancreas of 16-week-old male mice. Data represent the mean ± SD 
of four mice per genotype. 
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Figure 3-S7). PASK-/- mice on HFD exhibited reduced circulating 
insulin levels and adiposity. (A) Measurement of plasma insulin 
levels from 24-week-old HFD WT and PASK-/- male mice fasted for 8 
h. Data represent the mean ± SD of 10 mice per genotype. (B) Body 
fat mass in 23-week-old WT and PASK-/- mice on HFD, measured by 
dual energy x-ray absorptiometry	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Additional data not in 
original manuscript 
These data were not in the original manuscript however they 
strengthen the conclusions of the paper. PASK functions in a cell 
autonomous manner to regulate nutrient utilization. MEFs isolated from 
PASK-/- mice have increased glucose oxidation and increased ATP 
content (Fig 3-8). This supports the data found in shRNA knockdown of 
PASK in L6 cells. These data taken together indicate that in the absence of 
PASK cells become hypermetabolic.  
 It has been shown that PASK-/- mice and cells are hypermetabolic. 
In the absence of PASK mice are not able to normally regulate nutrient 
utilization. This failure to regulate nutrients in the mouse is due to a cell 
autonomous defect. These data indicate that PASK kinase is required for 
nutrient utilization however it does not indicate if PASK is sufficient to 
regulate nutrient utilization. We constructed L6 cell lines that over-express 
either PASK or PASK kinase dead (KD) which is suppressed by the 
addition of doxycycline. Over-expression of PASK causes a decrease in 
glucose oxidation, however PASK-KD over-expression does not induce the 
same decrease in glucose oxidation (Fig 3-9). These data indicate that 
PASK is sufficient to regulate nutrient utilization by a cell autonomous 
mechanism.  




















Figure 3-S8). PASK-/- mouse embryonic fibroblasts (MEF) have 
increased glucose oxidation and ATP content. MEFs were isolated 
from two littermates. Data represent mean+/- SD of triplicates per group. 
(A) Measurement of 14CO2 release from indicated MEFs incubated in 
[14C]glucose (B) Cellular ATP content measurement normalized to protein 
in extract.  
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Figure 3-S9). PASK over-expression L6 cell lines show decreased 
glucose oxidation. Glucose oxidation rates in L6 clones over-expressing 
either wild-type PASK or PASK kinase dead in the absence of doxycycline. 
Data represent mean+/- SD of triplicates per group. (A) Measurement of 
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Conclusions	  
 
 Every organism must strike a balance between energy consumption, for 
growth, and starvation. Growth requires the coordinated execution of biochemical 
processes, linked to nutrient availability and energy, by which organisms 
increase their size or cell number through the biosynthesis of new cellular 
components. Equally important is the ability to rapidly suppress these synthetic 
processes to conserve energy and survive in the presence of depleted nutrient 
conditions. Suppression of these pathways must be coordinated with mobilization 
of energy stores (glycogen and lipids), recycling of proteins and organelles 
through autophagy and inhibition of proliferation. Activation of these scavenging 
programs prevents death under conditions of fasting or starvation.  
The ability to coordinately up-regulate biosynthetic cellular processes in 
response to available nutrients is largely dependent on activation of TOR 
signaling and inhibition of AMPK signaling. However when nutrients are depleted 
the cell must rapidly respond by activation of AMPK signaling via the AMP:ATP 
ratio and inhibition of anabolic TOR signaling. The capacity to respond rapidly 
can be the difference between reproduction or death. In order to integrate the 
myriad of signals from both within and without the cell there are many signaling 
pathways that impinge on both TOR and AMPK signaling. One such protein is 
PAS kinase, which in S.cerevisiae can regulate glucose partitioning and growth. 
In mammals, loss of PASK leads to a hypermetabolic state and resistance to 
diet-induced obesity.  
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 Given the fundamental nature of coordinating growth decisions with 
available energy sources, the single celled eukaryote S. cerevisiae is a valuable 
tool for deciphering these signaling mechanisms. PAS kinase was originally 
characterized to be able to partition glucose in response to nonfermentative 
carbon sources or cell integrity stress. We have gone further to show that in the 
absence of TORC2 signaling that PAS kinase is necessary and sufficient for 
survival. Any mechanism that activates PAS kinase (over-expression, cell 
integrity stress, nonfermentative carbon sources) can suppress the lethality 
caused by an absence of TORC2 signaling.  PAS kinase activation leads to 
phosphorylation of the metabolic enzyme Ugp1. PAS kinase-dependent 
phosphorylation of Ugp1 does not affect enzymatic activity. However it induces a 
translocation from the cytoplasm to the cell periphery. At the cell periphery P-
Ugp1 nucleates the formation of a signaling complex that includes Rom2, a Rho1 
GEF and Ssd1, an RNA binding protein. The complex is able to induce activation 
of Rho1, presumably through inclusion of Rom2 within the complex. Rho1 
activation can act as a progrowth signal within the cell via polarization of the actin 
cytoskeleton and up-regulation of cell wall synthesis. Identification of this novel 
pathway increases our understanding of the integration of the signaling 
mechanisms of two nutrient responsive kinases, TOR and PAS kinase. This 
discovery also increases our understanding of the complex, integrated signaling 
that exists within the cell to coordinate nutrient availability to growth. Discovery of 
this novel pathway still leaves several major questions that remain unanswered. 
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Are there conditions in which TORC2 is inactivated and thereby PAS kinase is 
essential for growth? PAS kinase-dependent phosphorylation of Ugp1 is required 
for suppression of the Tor2 mutant. However it is not clear if the enzymatic 
activity of Ugp1 is required for suppression. P-Ugp1 nucleates the formation of a 
complex that includes Ssd1, an RNA binding protein, which brings up the 
possibility that RNA might be in the complex. If so, RNA might regulate some 
aspect of the complex activity or vice versa. Does formation of the complex and 
activation of Rho1 lead to activation of all of the pathways downstream of Rho1 
or only a subset and if so, which pathways are activated?  
PAS kinase has been shown to regulate nutrient partitioning and some 
aspects of polarized cell growth in S. cerevisiae. We have also shown that in 
mammals PAS kinase can regulate partitioning of nutrients. In particular, in the 
absence of PAS kinase mice are unable to properly regulate fat metabolism, 
which leads to a decrease in fat accumulation in the liver of mice on a high fat 
diet. These data taken together suggest that PAS kinase might be able to couple 
nutrient availability to growth decisions similar to TOR and AMPK. The effect of 
PAS kinase on growth remains to be fully elucidated.	  
